
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCB5E2292767F133E5E220010E73248.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="biomedicines">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Biomedicines">
<meta name="citation_title" content="iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development">
<meta name="citation_author" content="Eline Simons">
<meta name="citation_author_institution" content="Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium">
<meta name="citation_author" content="Bart Loeys">
<meta name="citation_author_institution" content="Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium">
<meta name="citation_author" content="Maaike Alaerts">
<meta name="citation_author_institution" content="Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium">
<meta name="citation_publication_date" content="2023 Jan 25">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="2">
<meta name="citation_firstpage" content="334">
<meta name="citation_doi" content="10.3390/biomedicines11020334">
<meta name="citation_pmid" content="36830871">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/pdf/biomedicines-11-00334.pdf">
<meta name="description" content="With the discovery of induced pluripotent stem cell (iPSCs) a wide range of cell types, including iPSC-derived cardiomyocytes (iPSC-CM), can now be generated from an unlimited source of somatic cells. These iPSC-CM are used for different purposes ...">
<meta name="og:title" content="iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="With the discovery of induced pluripotent stem cell (iPSCs) a wide range of cell types, including iPSC-derived cardiomyocytes (iPSC-CM), can now be generated from an unlimited source of somatic cells. These iPSC-CM are used for different purposes ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9953535">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/biomedicines11020334"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/biomedicines-11-00334.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9953535%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9953535/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9953535/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-biomedicines.png" alt="Biomedicines logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Biomedicines" title="Link to Biomedicines" shape="default" href="http://www.mdpi.com/journal/biomedicines" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Biomedicines</button></div>. 2023 Jan 25;11(2):334. doi: <a href="https://doi.org/10.3390/biomedicines11020334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/biomedicines11020334</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Biomedicines%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biomedicines%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Biomedicines%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Biomedicines%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simons%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Eline Simons</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Eline Simons</span></h3>
<div class="p">
<sup>1</sup>Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simons%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eline Simons</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Loeys%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Bart Loeys</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Bart Loeys</span></h3>
<div class="p">
<sup>1</sup>Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Loeys%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bart Loeys</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alaerts%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Maaike Alaerts</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Maaike Alaerts</span></h3>
<div class="p">
<sup>1</sup>Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alaerts%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maaike Alaerts</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">M Esther Gallardo</span><sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-biomedicines-11-00334">
<sup>1</sup>Cardiogenetics Research Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Antwerp, Belgium</div>
<div class="author-notes p"><div class="fn" id="c1-biomedicines-11-00334">
<sup>*</sup><p class="display-inline">Correspondence: <span>maaike.alaerts@uantwerpen.be</span></p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">M Esther Gallardo</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Dec 25; Revised 2023 Jan 20; Accepted 2023 Jan 22; Collection date 2023 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2023 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9953535  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36830871/" class="usa-link">36830871</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>With the discovery of induced pluripotent stem cell (iPSCs) a wide range of cell types, including iPSC-derived cardiomyocytes (iPSC-CM), can now be generated from an unlimited source of somatic cells. These iPSC-CM are used for different purposes such as disease modelling, drug discovery, cardiotoxicity testing and personalised medicine. The 2D iPSC-CM models have shown promising results, but they are known to be more immature compared to in vivo adult cardiomyocytes. Novel approaches to create 3D models with the possible addition of other (cardiac) cell types are being developed. This will not only improve the maturity of the cells, but also leads to more physiologically relevant models that more closely resemble the human heart. In this review, we focus on the progress in the modelling of inherited cardiac arrhythmias in both 2D and 3D and on the use of these models in therapy development and drug testing.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> iPSC, cardiac arrhythmia, iPSC-derived cardiomyocytes</p></section></section><section id="sec1-biomedicines-11-00334"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Since the discovery of induced pluripotent stem cells (iPSCs) in 2006 by Takahashi and Yamanaka [<a href="#B1-biomedicines-11-00334" class="usa-link" aria-describedby="B1-biomedicines-11-00334">1</a>], iPSCs have increasingly gained popularity in the scientific field; not only to perform stem cell research but also to create somatic cells derived from these iPSCs such as neurons [<a href="#B2-biomedicines-11-00334" class="usa-link" aria-describedby="B2-biomedicines-11-00334">2</a>], cardiomyocytes [<a href="#B3-biomedicines-11-00334" class="usa-link" aria-describedby="B3-biomedicines-11-00334">3</a>] and hepatic cells [<a href="#B4-biomedicines-11-00334" class="usa-link" aria-describedby="B4-biomedicines-11-00334">4</a>] amongst many others. The numerous advantages, such as access to difficult-to-access human cell types, the development of patient-specific cell types, decreased need for laboratory animals and less ethical concerns compared to embryonal stem cells (ESC), are well-known. However, there are also some drawbacks on the use of these derived cells such as variability, low differentiation efficiency and the immature state of the differentiated cells. Nevertheless, iPSC-derived cells are indispensable in the current cell-biology research community.</p>
<p>In 2009, Zwi et al. presented their work on the development of a way to differentiate iPSCs into cardiomyocytes [<a href="#B3-biomedicines-11-00334" class="usa-link" aria-describedby="B3-biomedicines-11-00334">3</a>]. Their iPSC-derived cardiomyocytes (iPSC-CM) expressed the cardiac specific markers cardiac troponin-I and sarcomeric α-actinin, were electrophysiologically active and they displayed the expected response to the admission of different drugs. Ever since, an increasing number of papers have been published using iPSC-CM to model diseases, perform drug and cardiotoxicity testing and develop new therapies.</p>
<p>In this review, we take a closer look at these recent developments focusing on cardiac arrhythmia disorders and the transition from 2D to 3D culture models (<a href="#biomedicines-11-00334-f001" class="usa-link">Figure 1</a>).</p>
<figure class="fig xbox font-sm" id="biomedicines-11-00334-f001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9953535_biomedicines-11-00334-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afee/9953535/23f21c36d66f/biomedicines-11-00334-g001.jpg" loading="lazy" height="314" width="775" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/biomedicines-11-00334-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic representation of different applications of iPSC-cardiomyocytes.</p></figcaption></figure></section><section id="sec2-biomedicines-11-00334"><h2 class="pmc_sec_title">2. iPSC-Derived Cardiomyocytes as Inherited Cardiac Arrhythmia Models</h2>
<p>Inherited cardiac arrhythmias are characterised by the dysfunction of cardiac ion channels, their accessory proteins or cell–cell contact proteins which can lead to ventricular arrhythmias and potential sudden cardiac death. The most well-known inherited cardiac arrhythmias include long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), short QT syndrome (SQTS) and arrhythmogenic cardiomyopathy (ACM). These diseases are caused by pathogenic variants in genes encoding components or accessory elements of these ion channels or desmosomes. The type of mutation (loss-of-function (LOF) or gain-of-function (GOF)) is also important in defining the disease outcome.</p>
<p>The arrhythmias mostly occur in the ventricles, making ventricular cardiomyocytes the most relevant cell type to investigate. Most of the currently used iPSC-CM differentiation protocols generate a mixture of atrial, ventricular and sinoatrial pacemaker cardiomyocytes, but with a clear overrepresentation/higher presence of ventricular cells. Ventricular action potentials (AP) are characterised by a more negative maximum diastolic potential, a rapid AP upstroke, a long plateau phase and an APD90/APD50 ratio ≤1.3/1.4 [<a href="#B5-biomedicines-11-00334" class="usa-link" aria-describedby="B5-biomedicines-11-00334">5</a>,<a href="#B6-biomedicines-11-00334" class="usa-link" aria-describedby="B6-biomedicines-11-00334">6</a>,<a href="#B7-biomedicines-11-00334" class="usa-link" aria-describedby="B7-biomedicines-11-00334">7</a>]. It is also possible to differentiate iPSCs directly into the specific cardiomyocyte types [<a href="#B8-biomedicines-11-00334" class="usa-link" aria-describedby="B8-biomedicines-11-00334">8</a>].</p>
<p>In 2018, Garg et al. reviewed the published iPSC-CM models of several channelopathies [<a href="#B9-biomedicines-11-00334" class="usa-link" aria-describedby="B9-biomedicines-11-00334">9</a>] and Pan et al. updated this review with the addition of ACM (<a href="#app1-biomedicines-11-00334" class="usa-link">Table S1 (Supplementary Materials)</a>) [<a href="#B10-biomedicines-11-00334" class="usa-link" aria-describedby="B10-biomedicines-11-00334">10</a>]. Here, the overview is updated (see <a href="#biomedicines-11-00334-t001" class="usa-link">Table 1</a>) with more recently published models.</p>
<section class="tw xbox font-sm" id="biomedicines-11-00334-t001"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Overview of published 2D iPSC-CM cardiac arrhythmia disease models.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Syndrome</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Causal Gene <br>Variant</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Experimental<br>Approach</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cellular Phenotype</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">LQTS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>KCNQ1</em><br>p.(Arg190Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, IF</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged AP, reduced I<sub>Ks</sub> current, ER retention, increased susceptibility to catecholamine-induced tachyarrhythmia, attenuation of this phenotype with beta blockade</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B6-biomedicines-11-00334" class="usa-link" aria-describedby="B6-biomedicines-11-00334">6</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>KCNH2</em> p.(Thr983Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, MEA, WB, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged APD50 and APD90, beat irregularity, EAD, decreased I<sub>Kr</sub> density, reduced channel surface expression, higher diastolic Ca<sup>2+</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B11-biomedicines-11-00334" class="usa-link" aria-describedby="B11-biomedicines-11-00334">11</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>CACNA1C</em> p.(Asn639Thr)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CardioExcyte 96, PC</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged Maximum Field Potential Duration and APD, slower Ca<sub>V</sub>1.2 voltage-dependent inactivation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B12-biomedicines-11-00334" class="usa-link" aria-describedby="B12-biomedicines-11-00334">12</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS/LQT</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>SCN5A</em><br>p.(1798insAsp)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced I<sub>Na</sub> peak current, persistent I<sub>Na</sub>, reduced Vmax, prolonged APD90</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B13-biomedicines-11-00334" class="usa-link" aria-describedby="B13-biomedicines-11-00334">13</a>]</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BrS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>SCN5A</em><br>p.(Arg620His)+<br>p.(Arg811His)<br><em>SCN5A</em><br>(c. 4190delA)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reductions in I<sub>Na</sub> and Vmax of AP, increased burden of triggered activity, abnormal calcium transients and beating interval variation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B14-biomedicines-11-00334" class="usa-link" aria-describedby="B14-biomedicines-11-00334">14</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>CACNB2</em><br>p.(Ser142Phe)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in peak I<sub>Ca-L</sub>, acceleration recovery of inactivation and altered voltage dependent inactivation, reduced APA and Vmax, reduced protein expression of the <em>CACNB2</em> gene, increased arrhythmia-like events, suppression of arrhythmic events by quinidine and bisoprolol</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B15-biomedicines-11-00334" class="usa-link" aria-describedby="B15-biomedicines-11-00334">15</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>SCN5A</em> p.(Val1405Met) <em>SCNB1</em><br>p.(Ala197Val)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in peak I<sub>Na</sub> density, reduced APA and V<sub>max</sub>, prolonged AP, more proarrhythmic events (EAD, DAD-like events), reduced Nav1.5 protein expression</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B16-biomedicines-11-00334" class="usa-link" aria-describedby="B16-biomedicines-11-00334">16</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>SCN5A</em><br>p.(Ser1812X)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, IF, MEA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced I<sub>Na</sub> and a delayed sodium channel activation, slowed AP upstroke velocity, reduced FP and CV, enhanced I<sub>to</sub> and an augmented I<sub>Ca-L</sub> window current, reduced Na<sub>V</sub>1.5 protein expression</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>]</td>
</tr>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">SQTS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>KCNH2</em><br>p.(Asn588Lys)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, IF, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shortening APD, Increased I<sub>Kr</sub> tail current, arrhythmic events, increased hERG expression, re-entrant arrhythmias</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B18-biomedicines-11-00334" class="usa-link" aria-describedby="B18-biomedicines-11-00334">18</a>,<a href="#B19-biomedicines-11-00334" class="usa-link" aria-describedby="B19-biomedicines-11-00334">19</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>KCNH2</em><br>p.(Thr618Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, WB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased I<sub>kr</sub>, shortened APD, beat-to-beat variability, increased membrane expression</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>]</td>
</tr>
<tr>
<td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">CPVT</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Phe2483Ileu)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, MEA, CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arrhythmias, DAD, forskolin can rescue these phenotypes</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B21-biomedicines-11-00334" class="usa-link" aria-describedby="B21-biomedicines-11-00334">21</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Phe2483Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Longer Ca<sup>2+</sup> sparks, higher diastolic Ca<sup>2+</sup> levels, irregular beating, SR calcium leak and lower load levels</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B22-biomedicines-11-00334" class="usa-link" aria-describedby="B22-biomedicines-11-00334">22</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Asp3638Ala)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AFM, CI, PC,</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Higher beat rate, diastolic SR Ca<sup>2+</sup> leak, weaker force contraction during stress, APD, Vmax and APA decreased during stress</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B23-biomedicines-11-00334" class="usa-link" aria-describedby="B23-biomedicines-11-00334">23</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Arg176Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CI</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aberrant diastolic SR Ca<sup>2+</sup> release, EAD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B24-biomedicines-11-00334" class="usa-link" aria-describedby="B24-biomedicines-11-00334">24</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Gln4201Arg)<br>p.(Arg420Gln)<br>p.(Phe2483Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI, qPCR, WB</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.(Gln4201Arg): decrease mRNA levels RYR2, protein similar, All mutants: longer sparks p.(Arg420Gln): lower spark frequency</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B25-biomedicines-11-00334" class="usa-link" aria-describedby="B25-biomedicines-11-00334">25</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>RYR2</em><br>p.(Phe13Leu)<br>p.(Leu14Pro)<br>p.(Arg15Pro)<br>p.(Arg176Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CI, WB, qPCR, MEA LEAP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased Ca<sup>2+</sup> amplitude and upstroke velocity, decrease in calcium transient duration, irregular beating, decreased beat rate</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-biomedicines-11-00334" class="usa-link" aria-describedby="B26-biomedicines-11-00334">26</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>CASQ2</em><br>p.(Asp307His)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI, EM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DADs, oscillatory arrhythmic, after-contractions and diastolic [Ca<sup>2+</sup>]<sub>i</sub> rise, less organised myofibrils, enlarged SR cisternae and reduced number of caveolae</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B27-biomedicines-11-00334" class="usa-link" aria-describedby="B27-biomedicines-11-00334">27</a>]</td>
</tr>
<tr>
<td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">ACM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>PKP2</em><br>p.(Leu614Pro)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, CI, qPCR, IF</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in rate of spontaneous cell contraction and amplitude under nifedipine, reduced expression plakophilin2 and plakoglobin</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B28-biomedicines-11-00334" class="usa-link" aria-describedby="B28-biomedicines-11-00334">28</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>DSG2</em><br>p.(Gly638Arg)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IF, PC, CI, qPCR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower APA and Vmax, decreased peak I<sub>Na</sub>, I<sub>NCX</sub>, I<sub>to</sub>, I<sub>SK</sub>, and I<sub>KATP</sub>, increased I<sub>Kr</sub>, more arrhythmogenic events</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B29-biomedicines-11-00334" class="usa-link" aria-describedby="B29-biomedicines-11-00334">29</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>DSG2</em><br>p.(Gly638Arg)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC, WB, qPCR</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of SK4 and NDPK-B, enhanced SK4 channel currents, pacemaker activity and more arrhythmic events</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B30-biomedicines-11-00334" class="usa-link" aria-describedby="B30-biomedicines-11-00334">30</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/biomedicines-11-00334-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p>Adapted and updated from Garg et al. (2018) and Pan et al. (2021) [<a href="#B9-biomedicines-11-00334" class="usa-link" aria-describedby="B9-biomedicines-11-00334">9</a>,<a href="#B10-biomedicines-11-00334" class="usa-link" aria-describedby="B10-biomedicines-11-00334">10</a>]. PC: patch clamp; IF: immunofluorescence; MEA: Multi electrode array; WB: Western Blot; CI: Calcium imaging; AFM: atomic force microscopy; AP: action potential; I<sub>Ks</sub>: slow delayed rectifier K+ current; ER: endoplasmic reticulum; APD50-90: Action potential duration at 50–90% of repolarisation; EAD: early after depolarisation; I<sub>Kr</sub>: rapid delayed rectifier K+ current; I<sub>Ca-L</sub>: L-type calcium current; APA: action potential amplitude; Vmax: maximum rate of rise of the action potential; I<sub>Na</sub>: sodium current; DAD: delayed after repolarisation; FP: field potential; CV: conduction velocity; I<sub>to</sub>: transient outward current; SR: sarcoplasmic reticulum; EM: electron microscope.</p></div></div></section><section id="sec2dot1-biomedicines-11-00334"><h3 class="pmc_sec_title">2.1. Long QT Syndrome</h3>
<p>Long QT syndrome has a prevalence of 1 in 2000 and is clinically diagnosed by a prolongation of the QT interval (heart rate-corrected QT interval ≥480 ms) on the electrocardiogram (ECG) [<a href="#B31-biomedicines-11-00334" class="usa-link" aria-describedby="B31-biomedicines-11-00334">31</a>]. Currently, there are 17 subtypes of LQTS based on the gene involved and the most common subtypes are LQT1, LQT2 and LQT3, caused by mutations in the <em>KCNQ1</em>, <em>KCNH2</em> and <em>SCN5A</em> genes, respectively [<a href="#B32-biomedicines-11-00334" class="usa-link" aria-describedby="B32-biomedicines-11-00334">32</a>]. Over the years, several LQTS iPSC-CM models have been published, the first in 2010 by Moretti et al. [<a href="#B6-biomedicines-11-00334" class="usa-link" aria-describedby="B6-biomedicines-11-00334">6</a>]. The latter investigated patient-specific iPSC-CM of three related LQT1 patients harbouring a p.(Arg190Gln) variant and showed a prolonged action potential duration at 90% of repolarisation (APD90) and lower potassium current densities compared to control individuals. This corresponded to the phenotype observed in the patients. Since then, several papers have been published describing LQTS iPSC-CM models of known pathogenic mutations (reviewed by Garg et al. [<a href="#B9-biomedicines-11-00334" class="usa-link" aria-describedby="B9-biomedicines-11-00334">9</a>], <a href="#app1-biomedicines-11-00334" class="usa-link">Table S1</a>). More recently, LQTS iPSC-CM models have been used to investigate the pathogenicity of variants of uncertain significance (VUS). For example, Garg et al. created a LQT2 iPSC-CM model harbouring the VUS p.(Thr983Ile) in the <em>KCNH2</em> gene. Using CRISPR/Cas9 technology, they developed both a homozygous VUS cell line as well as an isogenic control line. Both patch-clamp and multi-electrode array (MEA) experiments showed prolonged APD50, APD90 and field potential duration (FPD) in the homozygous as well as in the heterozygous VUS iPSC-CMs. In addition, more beat irregularity or early after depolarisations (EADs) were observed and the phenotype of the homozygous VUS iPSC-CMs resembled that of the known pathogenic p.(Ala561Val) <em>KCNH2</em> variant. Potassium (I<sub>Kr</sub>) current was decreased in the VUS cell line and restored to normal current densities in the isogenic control [<a href="#B11-biomedicines-11-00334" class="usa-link" aria-describedby="B11-biomedicines-11-00334">11</a>]. Chavali et al. took a different CRISPR/Cas9 approach when they introduced a VUS p.(Asn639Thr) in the <em>CACNA1C</em> gene into iPSCs to create a patient-independent iPSC model. Prolonged APD and FPD were recorded due to a slower inactivation of the Ca<sub>v</sub>1.2 current. As this cellular phenotype recapitulated the patient phenotype, the authors reclassified the VUS as probably pathogenic [<a href="#B12-biomedicines-11-00334" class="usa-link" aria-describedby="B12-biomedicines-11-00334">12</a>].</p></section><section id="sec2dot2-biomedicines-11-00334"><h3 class="pmc_sec_title">2.2. Brugada Syndrome</h3>
<p>Brugada syndrome is a cardiac arrhythmia with a prevalence ranging from 1 in 500 to 1 in 2000 and patients display a specific ST-segment elevation on the ECG. Many genes encoding ion channels and accessory proteins have been associated with the disease but only one is currently considered as causal, namely <em>SCN5A,</em> encoding the cardiac sodium channel Na<sub>V</sub>1.5. Mutations in <em>SCN5A</em> account for up to 20–25% of the BrS cases [<a href="#B33-biomedicines-11-00334" class="usa-link" aria-describedby="B33-biomedicines-11-00334">33</a>,<a href="#B34-biomedicines-11-00334" class="usa-link" aria-describedby="B34-biomedicines-11-00334">34</a>]. The first report on iPSC-CM in BrS was published by Davis et al. They modelled an iPSC-CM line harbouring a <em>SCN5A</em> mutation p.(1798insAsp) from a patient with an overlap syndrome of LQT/BrS and conduction disorder. Reduced and persistent sodium currents, slower upstroke velocity and prolongation of APD90 were observed in patients’ iPSC-CMs but not in controls, mimicking the LOF and GOF phenotype of this mutation [<a href="#B13-biomedicines-11-00334" class="usa-link" aria-describedby="B13-biomedicines-11-00334">13</a>]. Later, two iPSC-CM lines from BrS patients with <em>SCN5A</em> (p.(Arg620His)+ p.(Arg811His) and c. 4190delA) mutation were evaluated by Liang et al. Both cell lines showed abnormal action potentials (AP) compared to the controls as well as a reduced sodium current [<a href="#B14-biomedicines-11-00334" class="usa-link" aria-describedby="B14-biomedicines-11-00334">14</a>]. In 2021, Nijak et al. published a review on iPSC-CM models generated of BrS patients, included in <a href="#app1-biomedicines-11-00334" class="usa-link">Table S1</a> [<a href="#B35-biomedicines-11-00334" class="usa-link" aria-describedby="B35-biomedicines-11-00334">35</a>]. More recently, extra reports on BrS iPSC-CM models harbouring variants in <em>SCN5A</em> (p.(Val1405Met), p.(Ser1812X))<em>, SCN1B</em> (p.(Ala197Val)) and <em>CACNB2</em> (p.(Ser142Phe)) were published. Reduced expression of the encoded proteins was observed as well as reduced sodium or calcium currents leading to reduced action potential amplitude (APA) and maximum upstroke velocity (Vmax) but prolonged APDs [<a href="#B15-biomedicines-11-00334" class="usa-link" aria-describedby="B15-biomedicines-11-00334">15</a>,<a href="#B16-biomedicines-11-00334" class="usa-link" aria-describedby="B16-biomedicines-11-00334">16</a>,<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>]. Calcium imaging showed more proarrhythmic events such as EADs and DADs (early and delayed after depolarisations) in BrS cell lines compared to control cell lines [<a href="#B16-biomedicines-11-00334" class="usa-link" aria-describedby="B16-biomedicines-11-00334">16</a>]. A <em>SCN5A</em> p.(Ser1812X) variant resulted in reduced conduction velocity and proarrhythmic events [<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>].</p></section><section id="sec2dot3-biomedicines-11-00334"><h3 class="pmc_sec_title">2.3. Short QT Syndrome</h3>
<p>Short QT syndrome is diagnosed by a shortening of the QT interval on the ECG and has a prevalence ranging from 1 in 1000 to 1 in 5000 [<a href="#B36-biomedicines-11-00334" class="usa-link" aria-describedby="B36-biomedicines-11-00334">36</a>]. Causal GOF mutations are mostly found in potassium channel genes such as <em>KCNH2</em>, <em>KCNQ1</em> and <em>KCNJ2</em> [<a href="#B37-biomedicines-11-00334" class="usa-link" aria-describedby="B37-biomedicines-11-00334">37</a>]. The first iPSC-CM model of SQTS was published by El-Battrawy et al. in 2018 where one patient cell line with a p.(Asn588Lys) mutation in the <em>KCNH2</em> gene was compared to two control cell lines. They demonstrated an upregulation of the hERG channel expression and increased potassium currents (I<sub>Kr</sub>) resulting in a shortening of the action potential. During calcium-handling experiments, irregular beating, DAD-like and EAD-like arrhythmic events were recorded more in patient iPSC-CMs compared to control iPSC-CMs [<a href="#B18-biomedicines-11-00334" class="usa-link" aria-describedby="B18-biomedicines-11-00334">18</a>]. Later, the same mutation and another <em>KCNH2</em> p.(Thr618Ile) variant were modelled in iPSC-CMs and similar electrophysiological and molecular results were obtained [<a href="#B19-biomedicines-11-00334" class="usa-link" aria-describedby="B19-biomedicines-11-00334">19</a>,<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>]. An iPSC-based cardiac cell sheet model was created by Shinnawi and colleagues and an increase in susceptibility to the development of re-entrant arrhythmias recorded [<a href="#B19-biomedicines-11-00334" class="usa-link" aria-describedby="B19-biomedicines-11-00334">19</a>]. The p.(Thr618Ile) variant did not give rise to any arrhythmic events. However, there was an increased beat-to-beat variability in the patient cell line [<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>].</p></section><section id="sec2dot4-biomedicines-11-00334"><h3 class="pmc_sec_title">2.4. Catecholaminergic Polymorphic Ventricular Tachycardia Type</h3>
<p>CPVT most often occurs in young adults and athletes and is triggered by β-adrenergic stimulation related to exercise or emotional stress. It is mainly caused by mutations in Ca<sup>2+</sup>-handling related genes such as <em>RYR2</em> and <em>CASQ2</em> and has an estimated prevalence of 1 in 10,000 [<a href="#B37-biomedicines-11-00334" class="usa-link" aria-describedby="B37-biomedicines-11-00334">37</a>,<a href="#B38-biomedicines-11-00334" class="usa-link" aria-describedby="B38-biomedicines-11-00334">38</a>]. Both proteins are essential in the Ca<sup>2+</sup> handling in heart and muscle cells, responsible for the proper contraction of the cells. Different iPSC-CM CPVT models have been developed (reviewed by Garg et al. in 2018 [<a href="#B9-biomedicines-11-00334" class="usa-link" aria-describedby="B9-biomedicines-11-00334">9</a>], included in <a href="#app1-biomedicines-11-00334" class="usa-link">Table S1</a>). The first CPVT iPSC-CM model from a patient carrying a <em>RYR2</em> pathogenic variant (p.Phe2483Ile) was published in 2011 by Fatima et al. The analysis revealed more DAD events in patient iPSC-CMs compared to control iPSC-CMs and embryonal stem cell-derived cardiomyocytes (ESC-CM), recapitulating the CPVT phenotype. The underlying aberrant sarcoplasmic reticulum (SR) Ca<sup>2+</sup> release in the iPSC-CMs is responsible for the development of these DADs and arrhythmias [<a href="#B21-biomedicines-11-00334" class="usa-link" aria-describedby="B21-biomedicines-11-00334">21</a>]. The same variant was modelled using CRISPR/Cas9 by Wei et al. and showed longer calcium sparks in both hetero- and homozygous iPSC-CMs, larger SR Ca<sup>2+</sup> leak levels and smaller load levels which is consistent with higher diastolic Ca<sup>2+</sup> levels [<a href="#B22-biomedicines-11-00334" class="usa-link" aria-describedby="B22-biomedicines-11-00334">22</a>]. In 2018, Acimovic et al. published an iPSC-CM model of a CPVT patient with a <em>RYR2</em> p.(Asp3638Ala) variant. They found an increase in beat rate in the patient cell line compared to both iPSC- and ESC-derived CMs and a weaker response in force contraction upon stress induction. Calcium handling was normal under basal conditions, but upon stress more irregular Ca<sup>2+</sup>-release events in CPVT iPSC-CMs were recorded. Patch clamp data revealed a prolongation of the AP in basal conditions while during stress, APD, Vmax and the amplitude were lower in CPVT CMs compared to controls [<a href="#B23-biomedicines-11-00334" class="usa-link" aria-describedby="B23-biomedicines-11-00334">23</a>]. Several other reports on <em>RYR2</em> variants, either from patient-specific [<a href="#B24-biomedicines-11-00334" class="usa-link" aria-describedby="B24-biomedicines-11-00334">24</a>,<a href="#B26-biomedicines-11-00334" class="usa-link" aria-describedby="B26-biomedicines-11-00334">26</a>] or CRIPSR/Cas9-induced iPSC-CMs [<a href="#B25-biomedicines-11-00334" class="usa-link" aria-describedby="B25-biomedicines-11-00334">25</a>], show similar aberrant Ca<sup>2+</sup> handling although mutant lines also differ from each other, for example in the magnitude of the Ca<sup>2+</sup> leak or SR Ca<sup>2+</sup> content [<a href="#B24-biomedicines-11-00334" class="usa-link" aria-describedby="B24-biomedicines-11-00334">24</a>,<a href="#B25-biomedicines-11-00334" class="usa-link" aria-describedby="B25-biomedicines-11-00334">25</a>,<a href="#B26-biomedicines-11-00334" class="usa-link" aria-describedby="B26-biomedicines-11-00334">26</a>]. Two <em>CASQ2</em> (p.(Asp307His)) patient-specific iPSC-CM models showed DADs, oscillatory prepotentials, after-contractions and diastolic [Ca<sup>2+</sup>]<sub>i</sub> rises similar to <em>RYR2</em> CPVT models [<a href="#B27-biomedicines-11-00334" class="usa-link" aria-describedby="B27-biomedicines-11-00334">27</a>].</p></section><section id="sec2dot5-biomedicines-11-00334"><h3 class="pmc_sec_title">2.5. Arrhythmogenic Cardiomyopathy</h3>
<p>ACM, previously known as arrhythmogenic right ventricular cardiomyopathy (ARVC), is a rare disease (1 in 5000) that is characterised by fibrofatty myocardial replacement, leading to impaired ventricular systolic function and ventricular arrhythmias. Mutations in desmosomal genes such as <em>PKP2, DSG2, DSP, DSC2</em> and <em>JUP</em> play a prominent role in the development of the disease [<a href="#B39-biomedicines-11-00334" class="usa-link" aria-describedby="B39-biomedicines-11-00334">39</a>]. The first model of ARVC was published in 2013 by Ma et al. They created a patient-specific iPSC-CM model with a <em>PKP2</em> p.(Leu614Pro) mutation and showed downregulation of the expression of plakophilin and plakoglobin but no other desmosomal genes [<a href="#B28-biomedicines-11-00334" class="usa-link" aria-describedby="B28-biomedicines-11-00334">28</a>]. El-Battrawy and Buljubasic studied the same patient-derived iPSC-CM ACM model harbouring a mutation in the <em>DSG2</em> gene (p.(Gly638Arg)) [<a href="#B29-biomedicines-11-00334" class="usa-link" aria-describedby="B29-biomedicines-11-00334">29</a>,<a href="#B30-biomedicines-11-00334" class="usa-link" aria-describedby="B30-biomedicines-11-00334">30</a>]. The amplitude and the upstroke velocity of the AP were decreased as well as peak I<sub>Na</sub>, I<sub>NCX</sub>, I<sub>to</sub>, I<sub>SK</sub> and I<sub>KATP</sub>, while I<sub>Kr</sub> on the contrary was enhanced. Mutant iPSC-CMs showed more arrhythmogenic effects compared to control cells [<a href="#B29-biomedicines-11-00334" class="usa-link" aria-describedby="B29-biomedicines-11-00334">29</a>]. In addition, Buljubasic further investigated the underlying molecular mechanisms and revealed upregulation of SK4 channels and NDPK-B resulting in increased I<sub>SK4</sub>, pacemaker activity and arrhythmic events [<a href="#B30-biomedicines-11-00334" class="usa-link" aria-describedby="B30-biomedicines-11-00334">30</a>].</p></section></section><section id="sec3-biomedicines-11-00334"><h2 class="pmc_sec_title">3. From 2D to 3D</h2>
<p>In the iPSC-CM field, immaturity of the created iPSC-CM is a well-known problem. As the cardiomyocytes often only stay in culture for 30 days or less, it is not surprising that the phenotype of these cells does not fully recapitulate the phenotype of a mature native cardiomyocyte that has been developing for many years. Ahmed et al. (2020) reviewed the currently applied methods of maturation and pinpointed the main differences between fetal-like iPSC-CMs and adult cardiomyocytes. Methods to promote maturation include prolonged culture, addition of hormones (e.g., thyroid hormone) or cellular energy source (e.g., fatty acids such as palmitate, oleic acid, linoleic acid), co-culture, extracellular matrix, mechanical or electrical stimulation and 3D culture [<a href="#B40-biomedicines-11-00334" class="usa-link" aria-describedby="B40-biomedicines-11-00334">40</a>]. The latter is not only beneficial for the maturity of the cardiomyocytes but also enables the creation of 3D models that are more similar to native heart tissue. The heart consists of cardiomyocytes, but also various other cell types are present in the tissue such as endothelial cells (EC), fibroblasts (FB), pericytes, smooth muscle cells, immune cells (myeloid and lymphoid), adipocytes, mesothelial cells and neuronal cells [<a href="#B41-biomedicines-11-00334" class="usa-link" aria-describedby="B41-biomedicines-11-00334">41</a>]. Meanwhile, Pinto et al. found that CMs accounted for only 25–35% of the cells in the heart, ECs for 60% and FBs for less than 20%; Litviňuková found CMs represented 30% to 50% of the cells in atrial and ventricular samples, respectively, while ECs represented 10% and FBs 20% [<a href="#B41-biomedicines-11-00334" class="usa-link" aria-describedby="B41-biomedicines-11-00334">41</a>,<a href="#B42-biomedicines-11-00334" class="usa-link" aria-describedby="B42-biomedicines-11-00334">42</a>]. Adding these extra cell types to the model will make it even more physiologically relevant and likely more suitable for modelling pathological conditions and downstream applications such as drug or cardiotoxicity screening.</p>
<p>Below, we will discuss the development from 2D to 3D iPSC-CM cultures with or without other cell types using scaffold-free and scaffold-based techniques.</p>
<section id="sec3dot1-biomedicines-11-00334"><h3 class="pmc_sec_title">3.1. Scaffold-Free 3D Culture</h3>
<p>One method to create a 3D cell culture is the scaffold-free hanging droplet method in which iPSC-CMs are placed in a droplet in an ultra-low attachment plate with [<a href="#B43-biomedicines-11-00334" class="usa-link" aria-describedby="B43-biomedicines-11-00334">43</a>,<a href="#B44-biomedicines-11-00334" class="usa-link" aria-describedby="B44-biomedicines-11-00334">44</a>] or without [<a href="#B45-biomedicines-11-00334" class="usa-link" aria-describedby="B45-biomedicines-11-00334">45</a>,<a href="#B46-biomedicines-11-00334" class="usa-link" aria-describedby="B46-biomedicines-11-00334">46</a>] the addition of other cell types such as cardiac fibroblasts and endothelial cells. Beauchamp et al. and Ergir et al. reported a long-term stable 3D model of iPSC-CMs that was able to respond to electrical, pharmacological, and physical stimuli but Ca<sup>2+</sup> dyes only partially penetrated the culture and the CMs still displayed more fetal-like features such as shorter sarcomeres [<a href="#B45-biomedicines-11-00334" class="usa-link" aria-describedby="B45-biomedicines-11-00334">45</a>,<a href="#B46-biomedicines-11-00334" class="usa-link" aria-describedby="B46-biomedicines-11-00334">46</a>]. Sharma et al. combined iPSC-CM with human cardiac fibroblasts (HCFs) and human coronary artery endothelial cells to create cardiac spheroids containing a cardiac endothelial cell network that recapitulated better than the in vivo human heart [<a href="#B44-biomedicines-11-00334" class="usa-link" aria-describedby="B44-biomedicines-11-00334">44</a>].</p>
<p>Organoids are mainly formed by differentiating iPSC directly to CM (and other cell types) in ultra-low attachment plates. Drakhlis et al. generated a model of heart-forming organoids (HFO) by differentiating free-floating iPSC aggregates into cardiac organoids that resemble the early embryonic heart as they are composed of a myocardial layer and endocardial-like cells. They were able to model a <em>NKX2</em>.5 KO which resulted in similar cardiac malformations such as decreased cardiomyocyte adhesion and hypertrophy as observed in in vivo mouse studies [<a href="#B47-biomedicines-11-00334" class="usa-link" aria-describedby="B47-biomedicines-11-00334">47</a>]. A similar HFO protocol by Lewis-Israeli et al. using different small molecules’ concentrations and adding one WNT pathway modulation step enabled the generation of multiple cardiac-specific cell lineages such as endo- and epicardial cells, endothelial cells and cardiac fibroblasts [<a href="#B48-biomedicines-11-00334" class="usa-link" aria-describedby="B48-biomedicines-11-00334">48</a>]. Lee at al. started from embryonic bodies and generated chamber-forming HFOs. RNA-seq revealed that they more closely resembled the fetal heart than adult heart tissue, but here as well, several cell types were generated [<a href="#B49-biomedicines-11-00334" class="usa-link" aria-describedby="B49-biomedicines-11-00334">49</a>]. As such, a drawback of this technique is that the iPSC-CMs still display an immature phenotype but the HFOs are well suited to studying cardiac diseases linked to development.</p>
<p>Another scaffold-free method is used to create cardiac microtissues (cMT) where several (previously generated) cell types (CMs, ECs, FBs, …) are combined. Giacomelli et al. combined iPSC-derived ECs, iPSC-derived cardiac FBs and iPSC-CMs to form a microtissue displaying mature iPSC-CM ultrastructures such as elongated tubular myofibrils and T-tubule-like structures [<a href="#B50-biomedicines-11-00334" class="usa-link" aria-describedby="B50-biomedicines-11-00334">50</a>]. RNA-seq indicated a mature expression profile of the iPSC-CMs comparable to that of adult CMs. Electrophysiological maturation was proven by the presence of the typical AP notch, although this has also been observed in 2D cultures [<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>,<a href="#B51-biomedicines-11-00334" class="usa-link" aria-describedby="B51-biomedicines-11-00334">51</a>]. As a proof-of-concept they created a cMT consisting of healthy iPSC-CMs and iPSC-ECs combined with mutant cardiac FB of an ACM patient with a <em>PKP2</em> (c.2013delC, p.(Lys672ArgfsX12)) mutation (<a href="#biomedicines-11-00334-t002" class="usa-link">Table 2</a>) and found reduced Cx43 expression in ACM cMT as well as arrhythmic behaviour [<a href="#B50-biomedicines-11-00334" class="usa-link" aria-describedby="B50-biomedicines-11-00334">50</a>], highlighting the importance of the presence of these non-myocytes in the model. In another paper, a LQTS cMT harbouring a <em>KCNQ1</em> p.(Arg594Gln) variant, showed a prolonged field potential compared to wild-type cMT [<a href="#B52-biomedicines-11-00334" class="usa-link" aria-describedby="B52-biomedicines-11-00334">52</a>] proving that the cMT can recapitulate the disease phenotype (<a href="#biomedicines-11-00334-t002" class="usa-link">Table 2</a>). However, as 2D models already showed this phenotype, the MT model was not of specific added value in this case.</p>
<section class="tw xbox font-sm" id="biomedicines-11-00334-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Overview of published 3D iPSC-CM arrhythmia models.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">3D Model</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease/Gene/<br>Variant</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cellular Phenotype</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiac<br>Microtissue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACM<br><em>PKP2</em><br>(c.2013delC, p.(Lys672ArgfsX12))</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower Cx43 expression and arrhythmic behaviour of ACM cMT consisting of control CM and EC and ACM cardiac fibroblasts</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B50-biomedicines-11-00334" class="usa-link" aria-describedby="B50-biomedicines-11-00334">50</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiac<br>Microtissue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQTS<br><em>KCNQ1</em><br>p.(Arg594Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged field potential duration (FPD), β-adrenergic stimulation shortened the RR interval and decreased the FPD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B52-biomedicines-11-00334" class="usa-link" aria-describedby="B52-biomedicines-11-00334">52</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Engineered heart tissue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQTS<br><em>KCNH2</em><br>p.(Ala614Val)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">APD prolongation (via ArcLight), re-entrant arrhythmic activity after I<sub>Kr</sub> blocking with dofetilide</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-biomedicines-11-00334" class="usa-link" aria-describedby="B53-biomedicines-11-00334">53</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Engineered heart tissue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br><em>CASQ2</em><br>p.(Asp307His)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">More [Ca<sup>2+</sup>]<sub>i</sub> transient abnormalities and arrhythmias compared to control EHT but less than single cell CPVT iPSC-CM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B53-biomedicines-11-00334" class="usa-link" aria-describedby="B53-biomedicines-11-00334">53</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/biomedicines-11-00334-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec3dot2-biomedicines-11-00334"><h3 class="pmc_sec_title">3.2. Scaffold-Based 3D Culture</h3>
<p>Another frequently used method is scaffold-based culture. These scaffolds consist of (decellularised) extracellular matrix (ECM) [<a href="#B54-biomedicines-11-00334" class="usa-link" aria-describedby="B54-biomedicines-11-00334">54</a>], natural or synthetic polymers [<a href="#B55-biomedicines-11-00334" class="usa-link" aria-describedby="B55-biomedicines-11-00334">55</a>,<a href="#B56-biomedicines-11-00334" class="usa-link" aria-describedby="B56-biomedicines-11-00334">56</a>] and can be combined as a hydrogel in an organised well-defined shape or in certain orientations [<a href="#B57-biomedicines-11-00334" class="usa-link" aria-describedby="B57-biomedicines-11-00334">57</a>]. Fong et al. tested the effect of adult and fetal extracellular matrix from decellularised bovine adult and fetal heart tissue on the maturity of the CMs in both 2D and 3D cultures. Adult heart ECM improved maturation, demonstrated by increased expression of several calcium-handling genes and enhanced calcium signalling, both in 2D and 3D culture with the highest expression levels observed in 3D cultured iPSC-CMs. However, there was no improvement on the formation of T-tubules [<a href="#B54-biomedicines-11-00334" class="usa-link" aria-describedby="B54-biomedicines-11-00334">54</a>].</p>
<p>In engineered heart tissue (EHT) iPSC-CMs are grown on hydrogel scaffolds wrapped around two flexible pillars that have the ability to mechanically stimulate the cells and improve maturation. Several published models indeed prove that CMs grown in EHT present more mature electrophysiological properties such as action potential amplitude and upstroke velocity and more mature rod-shape morphology and sarcomere alignment [<a href="#B58-biomedicines-11-00334" class="usa-link" aria-describedby="B58-biomedicines-11-00334">58</a>]. Expression profiles as well as the cardiac ultrastructure, bioenergetics and t-tubule formation of stimulated EHT are more in line with adult cardiac tissue then fetal cardiac tissue [<a href="#B59-biomedicines-11-00334" class="usa-link" aria-describedby="B59-biomedicines-11-00334">59</a>]. To improve maturation even more, Lu et al. induced progressive stretch on the EHT which led to higher contractility and passive elasticity, more mature excitation/contraction coupling and a higher ratio of beta-myosin heavy chain (MHC) by alpha-MHC mRNA [<a href="#B60-biomedicines-11-00334" class="usa-link" aria-describedby="B60-biomedicines-11-00334">60</a>]. Goldfracht et al. combined the use of ECM with EHT, and in comparison, using a 2D model they found an increased expression of cardiac-related genes and the cardiomyocytes were arranged anisotropically and developed relatively elongated and oriented cell alignments. They created a LQTS2 (<em>KCNH2</em> p.(Ala614Val)) and CPVT2 (<em>CASQ2</em> p.(Asp307His)) (<a href="#biomedicines-11-00334-t002" class="usa-link">Table 2</a>) model and using voltage and calcium dyes, AP prolongation in LQTS iPSC-CM was revealed while the CPVT cell model showed abnormal calcium transients and more arrhythmias under stress conditions, indicating that these EHT models can be used to study channelopathies. In comparison with a 2D single cell model, the EHT showed less frequent, severe or complicated arrhythmogenic activity which is clinically more relevant as the extremely high incidence of arrhythmias as recorded in a single cell model would probably be incompatible with life. Re-entrant arrhythmias were not observed at baseline in the LQT-EHT but they were developed after blocking the I<sub>Kr</sub>, mimicking the clinical situation in LQT patients challenged with a QT prolonging agent [<a href="#B53-biomedicines-11-00334" class="usa-link" aria-describedby="B53-biomedicines-11-00334">53</a>]. The major advantage of this technique is the maturation state of the CMs, but special equipment for the generation of this EHT is needed, which might not be available for every lab.</p></section><section id="sec3dot3-biomedicines-11-00334"><h3 class="pmc_sec_title">3.3. Heart-on-a-Chip</h3>
<p>Heart-on-a-chip is a method to culture iPSC-CM—with or without other cell types —in a 2D or 3D manner on a microfluidic device in a chamber with built-in channels for fluids, microactuators and microsensors [<a href="#B61-biomedicines-11-00334" class="usa-link" aria-describedby="B61-biomedicines-11-00334">61</a>]. Microactuators can give either electrical or mechanical stimuli to the cells/tissue, while the sensors record electrophysiological signals or contraction force [<a href="#B61-biomedicines-11-00334" class="usa-link" aria-describedby="B61-biomedicines-11-00334">61</a>]. Heart-on-a-chip has been used for drug toxicity assessments and maturation was shown to be improved through electrical and mechanical stimulation [<a href="#B62-biomedicines-11-00334" class="usa-link" aria-describedby="B62-biomedicines-11-00334">62</a>]. Although some cardiac disease models such as ischaemia and fibrosis have been investigated using the heart-on-a-chip method [<a href="#B63-biomedicines-11-00334" class="usa-link" aria-describedby="B63-biomedicines-11-00334">63</a>,<a href="#B64-biomedicines-11-00334" class="usa-link" aria-describedby="B64-biomedicines-11-00334">64</a>], to date there are no publications on its use for inherited cardiac arrhythmias. The technique is currently still under development and the primary focus is on its application for drug cardiotoxicity screening. Even for this application, there are some challenges such as standardisation, reliable tissue manufacturing, high throughput, high content functional readouts and high cost, that still need to be solved before heart-on-a-chip can be more widely used [<a href="#B65-biomedicines-11-00334" class="usa-link" aria-describedby="B65-biomedicines-11-00334">65</a>,<a href="#B66-biomedicines-11-00334" class="usa-link" aria-describedby="B66-biomedicines-11-00334">66</a>].</p></section></section><section id="sec4-biomedicines-11-00334"><h2 class="pmc_sec_title">4. Drug and Gene Therapy Testing</h2>
<section id="sec4dot1-biomedicines-11-00334"><h3 class="pmc_sec_title">4.1. Cardiotoxicity Screening</h3>
<p>A first application of iPSC-CMs and their ability to model/display/show arrhythmias and structural pathology is testing of the cardiotoxicity of a drug under development. Cardiotoxicity and arrhythmia induction such as life-threatening Torsade de pointes (TdP) are a main reason for preclinical and clinical drug failure and withdrawal from the market. In 2013, the Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative was founded to overcome the low specificity of the preclinical studies and clinical trials at that time [<a href="#B67-biomedicines-11-00334" class="usa-link" aria-describedby="B67-biomedicines-11-00334">67</a>]. One of the novel components is testing the effect of a drug in vitro in iPSC-CM. A total of 28 compounds with known cardiac effects were tested in commercially available iPSC-CMs using a MEA system and voltage-sensitive dyes and could be classified as high-, intermediate- and low-risk for TdP [<a href="#B68-biomedicines-11-00334" class="usa-link" aria-describedby="B68-biomedicines-11-00334">68</a>]. To confirm these findings, these drugs were tested over several laboratories/facilities, commercial cardiomyocyte types and different MEA platforms and reproducible concentration-dependent electrophysiological responses were reported, indicating that iPSC-CMs can predict clinical QT prolongation and/or arrhythmogenic potential of drug compounds [<a href="#B69-biomedicines-11-00334" class="usa-link" aria-describedby="B69-biomedicines-11-00334">69</a>,<a href="#B70-biomedicines-11-00334" class="usa-link" aria-describedby="B70-biomedicines-11-00334">70</a>,<a href="#B71-biomedicines-11-00334" class="usa-link" aria-describedby="B71-biomedicines-11-00334">71</a>]. Lee at al showed that addition of a contractility assay (impedance measurement) into the evaluation of cardiotoxicity provides/allows more mechanistic insights on the drug effect [<a href="#B72-biomedicines-11-00334" class="usa-link" aria-describedby="B72-biomedicines-11-00334">72</a>]. As discussed above, 3D heart-on-a-chip models are also being tested, holding promise for even better prediction of cardiotoxic and pro-arrhythmic drug effects as they better recapitulated the clinical effects compared to 2D iPSC-CM models as they present occasionally with arrhythmias that are not reported in adult cardiomyocytes [<a href="#B73-biomedicines-11-00334" class="usa-link" aria-describedby="B73-biomedicines-11-00334">73</a>,<a href="#B74-biomedicines-11-00334" class="usa-link" aria-describedby="B74-biomedicines-11-00334">74</a>]. Regarding inherited cardiac arrhythmias, variable expressivity is a known characteristic, with many individuals who carry pathogenic variants remaining asymptomatic throughout life. However, specific drugs can also elicit life-threatening arrhythmias in these carriers/patients and patients are recommended to avoid taking them. Using iPSC-CM with such pathogenic variants in cardiotoxicity screening could be a valuable option to predict these adverse effects in a subset of the population.</p></section><section id="sec4dot2-biomedicines-11-00334"><h3 class="pmc_sec_title">4.2. Drug Testing</h3>
<p>In addition to cardiotoxicity, iPSC-CM can also be deployed to test compounds that could (partially) restore the phenotype of inherited cardiac arrhythmias models (<a href="#biomedicines-11-00334-t003" class="usa-link">Table 3</a>). Two recent publications reported a 2D LQT3 (<em>SCN5A</em> p.(Phe1473Cys)) model that was used to test mexiletine and different analogues in their ability to reduce the prolongation of the AP and they found that the analogues were more potent and selective in inhibiting the late sodium current, responsible for the APD prolongation in patients. In addition, they did not induce AP prolongation or EADs, known off-target effects of mexiletine due to unwanted inhibition of hERG [<a href="#B75-biomedicines-11-00334" class="usa-link" aria-describedby="B75-biomedicines-11-00334">75</a>], and were still able to suppress arrhythmias [<a href="#B76-biomedicines-11-00334" class="usa-link" aria-describedby="B76-biomedicines-11-00334">76</a>,<a href="#B77-biomedicines-11-00334" class="usa-link" aria-describedby="B77-biomedicines-11-00334">77</a>]. Verapamil and lidocaine were able to reduced APD in another LQT model harbouring to variants (<em>KCNQ1</em> p.(Gly219Glu)/<em>TRPM4</em> p.(Thr160Met)) [<a href="#B78-biomedicines-11-00334" class="usa-link" aria-describedby="B78-biomedicines-11-00334">78</a>].</p>
<section class="tw xbox font-sm" id="biomedicines-11-00334-t003"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Overview of published drug testing in iPSC-CM arrhythmia models.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of Action</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease<br>Gene<br>Mutation </th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect on Phenotype</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexiletine analogues </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 1B antiarrhythmic drug, inhibits I<sub>Na</sub>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>SCN5A</em><br>p.(Phe1473Cys),<br>p.(Asn406Lys)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexiletine: I<sub>NaL</sub> inhibition and APD shortening at lower dose but modest prolongation at higher dose and proarrhythmic response<br>Analogues ‘MexA2′ and ‘MexA5′: more potent and selective for I<sub>NaL</sub> over I<sub>NaP</sub> and I<sub>Kr</sub>, Shortening of APD and suppression of arrhythmia<br>Analogues ’13, 14, 25′: shortening of APD and no EADs</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B76-biomedicines-11-00334" class="usa-link" aria-describedby="B76-biomedicines-11-00334">76</a>,<a href="#B77-biomedicines-11-00334" class="usa-link" aria-describedby="B77-biomedicines-11-00334">77</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verapamil,<br>Lidocaine</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calcium channel blocker<br>Sodium channel blocker</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>KCNQ1</em> p.(Gly219Glu)/ <em>TRPM4</em> p.(Thr160Met)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in APD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B78-biomedicines-11-00334" class="usa-link" aria-describedby="B78-biomedicines-11-00334">78</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Telmisartan, GW0742</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Agonists of the PPARδ pathway, stabilise the active PKA-phosphorylated state of hERG</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>KCNH2</em><br>p.(Ala561Thr)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in APD50, APD90 and triangularisation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B79-biomedicines-11-00334" class="usa-link" aria-describedby="B79-biomedicines-11-00334">79</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NS1643</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Change the voltage dependence of inactivation of hERG</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>KCNH2</em><br>p.(Ala561Thr)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reductions in APD50, APD90 and triangularisation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B79-biomedicines-11-00334" class="usa-link" aria-describedby="B79-biomedicines-11-00334">79</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lumacaftor</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trafficking chaperone during protein folding</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>KCNH2</em><br>Trafficking<br>p.(Ala561Val),<br>(IVS9-28A/G), p.(Asn633Ser), p.(Arg685Pro), p.(Gly604Ser)<br>Synthesis<br>p.(Ser428X), p.(Arg366X)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>Trafficking variants</em><br>Increased membrane localisation, reduced cFPD and APD90, increase in I<sub>Kr</sub> current densities, reduced calcium transient irregularities and frequency<br>p.(Gly604Ser): increased membrane expression, no effect on APD90<br><em>Other variants</em><br>Reduced calcium transient irregularities and frequency, no effect on cFPD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B80-biomedicines-11-00334" class="usa-link" aria-describedby="B80-biomedicines-11-00334">80</a>,<a href="#B81-biomedicines-11-00334" class="usa-link" aria-describedby="B81-biomedicines-11-00334">81</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICA-105574</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type II I<sub>Kr</sub> activator (impairs transition to the inactivated state)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LQT<br><em>KCNH2</em><br>p.(Thr983Ile), <br>p.( Ala422Thr) </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased I<sub>Kr</sub>, shortening APD/cFPD in patient and control, shortened calcium transient, at higher concentrations (10–30 µM): cessation of the spontaneous calcium transients</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B11-biomedicines-11-00334" class="usa-link" aria-describedby="B11-biomedicines-11-00334">11</a>,<a href="#B82-biomedicines-11-00334" class="usa-link" aria-describedby="B82-biomedicines-11-00334">82</a>]</td>
</tr>
<tr>
<td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ajmaline</td>
<td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Class IA anti-arrhythmic drug inhibits I<sub>Na</sub>, I<sub>to</sub> or I<sub>Kr</sub>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br>Unknown mutation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No difference between patient and control</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B83-biomedicines-11-00334" class="usa-link" aria-describedby="B83-biomedicines-11-00334">83</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>SCN10A</em> p.(Arg1268Gln)/p.(Arg1250Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged APD50 and APD90, reduced APA and Vmax</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B84-biomedicines-11-00334" class="usa-link" aria-describedby="B84-biomedicines-11-00334">84</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>SCN1B</em> p.(Leu210Pro)/<br>p.(Pro213Thr)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced APA and Vmax</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B85-biomedicines-11-00334" class="usa-link" aria-describedby="B85-biomedicines-11-00334">85</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cilostazol, Milrinone</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphodiesterase III inhibitors, increase I<sub>Ca</sub> and suppress I<sub>to</sub>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>SCN5A</em><br>p.(Ser1812X)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in I<sub>to</sub>, decreased arrhythmic beating, no EAD- or EAD-triggered activities</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bisoprolol</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Beta blocker</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>CACNB2</em> p.(Ser142Phe)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced arrhythmic events and reduced variation in the beat-to-beat interval time at 30 nM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B15-biomedicines-11-00334" class="usa-link" aria-describedby="B15-biomedicines-11-00334">15</a>]</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Quinidine</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Class I antiarrhythmic agent, blocking I<sub>to</sub>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>CACNB2</em> p.(Ser142Phe)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced arrhythmic events</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B15-biomedicines-11-00334" class="usa-link" aria-describedby="B15-biomedicines-11-00334">15</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BrS<br><em>SCN5A</em> p.(Val1405Met)<br><em>SCN1B</em><br>p.(Ala197Val)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elimination of arrhythmic events (EAD, DAD), Vmax, APA, and RMP reduced in control and patients’ groups</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B16-biomedicines-11-00334" class="usa-link" aria-describedby="B16-biomedicines-11-00334">16</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SQT<br><em>KCNH2</em><br>p.(Thr618Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged APD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SQT<br><em>KCNH2</em> p.(Asn588Lys)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced Vmax, prolonged APD, elimination of arrhythmic events</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B18-biomedicines-11-00334" class="usa-link" aria-describedby="B18-biomedicines-11-00334">18</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxin BmKKx2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selective I<sub>Kr</sub> blocker</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SQT<br><em>KCNH2</em><br>p.(Thr618Ile)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged APD</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ivabradine, <br>Ajmaline, <br>Mexiletine</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitor of the pacemaker funny current <br>Class IA anti-arrhythmic drug, inhibits I<sub>Na</sub>, I<sub>to</sub> or I<sub>Kr</sub><br>Class 1B antiarrhythmic drug</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SQT<br><em>KCNH2</em> p.(Asn588Lys)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolonged APD90, reduced number of arrhythmic events</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B86-biomedicines-11-00334" class="usa-link" aria-describedby="B86-biomedicines-11-00334">86</a>]</td>
</tr>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">MiCUps<br>(efsevin, kaempferol, ezetimibe, disulfiram)</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Mitochondrial Ca<sup>2+</sup> uptake enhancers</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br><em>RYR2</em><br>p.(Ser406Leu) </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced number of cells displaying Ca<sup>2+</sup> waves and reduced frequency of Ca<sup>2+</sup> waves</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B87-biomedicines-11-00334" class="usa-link" aria-describedby="B87-biomedicines-11-00334">87</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br>unknown mutation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced Ca<sup>2+</sup> waves</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B88-biomedicines-11-00334" class="usa-link" aria-describedby="B88-biomedicines-11-00334">88</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Autocamtide-2-related inhibitory peptide (AIP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) inhibitory peptide</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br><em>RYR2</em> p.(Ser404Arg)/p.(Asn658Ser), p.(Gly3946Ser)/p.(Gly1885Glu)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced abnormal Ca<sup>2+</sup> transients, reduced frequency of Ca<sup>2+</sup> sparks, restored regular and spontaneous Ca<sup>2+</sup> transients</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B89-biomedicines-11-00334" class="usa-link" aria-describedby="B89-biomedicines-11-00334">89</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetracaine derivative EL20</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targeted inhibition of RyR2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br><em>RYR2</em><br>p.(Arg176Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced the Ca<sup>2+</sup> spark frequency, prevented pacing-evoked Ca<sup>2+</sup> oscillations</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B24-biomedicines-11-00334" class="usa-link" aria-describedby="B24-biomedicines-11-00334">24</a>]</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nadolol, <br>Flecainide</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-selective beta blocker<br>Class IC anti-arrhythmic agent inhibits I<sub>Na</sub> and I<sub>Kr</sub>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPVT<br><em>RYR2</em><br>p.(Phe13Leu), p.(Leu14Pro), p.(Arg15Pro), p.(Arg176Gln)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced Ca<sup>2+</sup> transient amplitude, reduced spontaneous Ca<sup>2+</sup> release, reduced Ca<sup>2+</sup> sparking activity, decreased irregularities in beat period and spontaneous beat rate</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-biomedicines-11-00334" class="usa-link" aria-describedby="B26-biomedicines-11-00334">26</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/biomedicines-11-00334-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Several LQT2 models, with pathogenic variants in the <em>KCNH2</em> (hERG channel) have also been used to test drugs. Telmisartan and GW0742 are agonists of the PPARδ pathway, which helps hERG to stabilise the PKA-phosphorylated active state of the channel opening at more negative potentials. Duncan et al. tested these agonists in a patient iPSC-CM model harbouring a <em>KCNH2</em> p.(Ala561Thr) variant and found a 20% reduction in APD for both compounds, which is comparable to the observed effect of NS1643 (also 20% APD shortening), a known compound that reduces inactivation of the hERG channel [<a href="#B79-biomedicines-11-00334" class="usa-link" aria-describedby="B79-biomedicines-11-00334">79</a>]. Mehta et al. created iPSC-CMs of five patients with either disrupted <em>KCNH2</em> trafficking (p.(Ala561Val), (IVS9-28A/G)) or synthesis (p.(Ser428X), p.(Arg366X)) to test the use of lumacaftor as a treatment option as the drug acts as a chaperone during protein folding. As predicted, they found higher <em>KCNH2</em> expression and shortened field potentials after 7 days of treatment with lumacaftor in patients with trafficking defect mutations but not in patients with disrupted synthesis of the hERG channel [<a href="#B80-biomedicines-11-00334" class="usa-link" aria-describedby="B80-biomedicines-11-00334">80</a>]. Two of the patients received treatment with lumacaftor and Ivacaftor and indeed showed a shorter QTc, however this shortening was not as pronounced as in the in vitro model indicating that the translation from in vitro to in vivo is not straightforward [<a href="#B90-biomedicines-11-00334" class="usa-link" aria-describedby="B90-biomedicines-11-00334">90</a>]. Another study also tested lumacaftor on three LQT2 (<em>KCNH2</em>) patient iPSC-CM lines with different pathogenic variants and found rescued phenotypes in two (p.(Asn633Ser), p.(Arg685Pro)) of the three lines. For the third one (p.(Gly604Ser)), on the other hand, they saw a prolongation of the AP after administration of the compound, which could be explained by the dominant-negative effect that was observed next to the trafficking defect caused by the third variant [<a href="#B81-biomedicines-11-00334" class="usa-link" aria-describedby="B81-biomedicines-11-00334">81</a>]. Another compound (ICA-105574, a type II I<sub>Kr</sub> activator) was used by two groups and tested both on VUS (p.(Thr983Ile)) and pathogenic (p.(Ala422Thr) LQT2 iPSC-CM models. They both saw a shortening of the action potential, field potential or calcium transient but with the risk of overcorrection at higher concentrations which might induce arrhythmic events [<a href="#B11-biomedicines-11-00334" class="usa-link" aria-describedby="B11-biomedicines-11-00334">11</a>,<a href="#B82-biomedicines-11-00334" class="usa-link" aria-describedby="B82-biomedicines-11-00334">82</a>].</p>
<p>Ajmaline is a class IA anti-arrhythmic drug that can be used to diagnose BrS patients. Studies have already shown that ajmaline can inhibit various currents, including I<sub>Na</sub>, I<sub>to</sub> or I<sub>Kr</sub> [<a href="#B83-biomedicines-11-00334" class="usa-link" aria-describedby="B83-biomedicines-11-00334">83</a>]. In the iPSC-CM of a BrS patient without a known genetic cause ajmaline had the same blocking effect on both the repolarisation and depolarisation caused by an inhibition of both I<sub>Na</sub> and I<sub>Kr</sub> as observed in the control iPSC-CMs. In an iPSC-CM model harbouring two <em>SCN10A</em> (p.(Arg1268Gln)/p.(Arg1250Gln) variants there was a more pronounced reduction in APA and Vmax compared to control iPSC-CMs [<a href="#B84-biomedicines-11-00334" class="usa-link" aria-describedby="B84-biomedicines-11-00334">84</a>]. The same was observed in a <em>SCN1B</em> (p.(Leu210Pro)/p.(Pro213Thr)) iPSC-CM model [<a href="#B85-biomedicines-11-00334" class="usa-link" aria-describedby="B85-biomedicines-11-00334">85</a>]. Cilostazol and milrinone, two phosphodiesterase III inhibitors, increased I<sub>Ca</sub> and suppressed I<sub>to</sub> by increasing the heart rate [<a href="#B91-biomedicines-11-00334" class="usa-link" aria-describedby="B91-biomedicines-11-00334">91</a>]. These were tested on BrS iPSC-CM models from two patients carrying a <em>SCN5A</em> p.(Ser1812X) variant, which resulted in a reduction in I<sub>to</sub> and arrhythmic beating [<a href="#B17-biomedicines-11-00334" class="usa-link" aria-describedby="B17-biomedicines-11-00334">17</a>]. Bisoprolol, a beta blocker, was recently tested in a <em>CACNB2</em> p.(Ser142Phe) iPSC-CM model and reduced variation in beat-to-beat interval time as well as arrhythmic events. Quinidine, a class I antiarrhythmic agent, on the other hand, only reduced arrhythmic events [<a href="#B15-biomedicines-11-00334" class="usa-link" aria-describedby="B15-biomedicines-11-00334">15</a>]. The same anti-arrhythmic effect of quinidine was observed in a <em>SCN5A</em> (p.(Val1405Met)) and <em>SCN1B</em> (p.(Ala197Val)) iPSC-CM model [<a href="#B16-biomedicines-11-00334" class="usa-link" aria-describedby="B16-biomedicines-11-00334">16</a>].</p>
<p>Guo et al. tested quinidine in an iPSC-CM model of a SQT (<em>KCNH2</em>, p.(Thr618Ile)) patient who was already receiving quinidine treatment. The cell model confirmed the beneficial effect of quinidine as APD was prolonged, comparable to the APD of the isogenic control. Next to quinidine, a short peptide derived from a scorpion, BmKKx2, prolonged the APD by targeting the <em>KCNH2</em> gene [<a href="#B20-biomedicines-11-00334" class="usa-link" aria-describedby="B20-biomedicines-11-00334">20</a>]. In another model (<em>KCNH2</em> p.(Asn588Lys)), quinidine reduced Vmax, prolonged APD and abolished arrhythmic events while sotalol and metoprolol did not have an effect [<a href="#B18-biomedicines-11-00334" class="usa-link" aria-describedby="B18-biomedicines-11-00334">18</a>]. Ivabradine, ajmaline, and mexiletine prolonged APD and reduced arrhythmic events in the same iPSC-CM model [<a href="#B86-biomedicines-11-00334" class="usa-link" aria-describedby="B86-biomedicines-11-00334">86</a>].</p>
<p>One way to prevent arrhythmias in CPVT is to upregulate the calcium uptake by the mitochondria by, for example, mitochondrial Ca<sup>2+</sup> uptake enhancers (MiCUp) such as efsevin and kaempferol [<a href="#B87-biomedicines-11-00334" class="usa-link" aria-describedby="B87-biomedicines-11-00334">87</a>]. These MiCUps were tested both in mice and <em>RYR2</em> (p. (Ser406Leu)) patient iPSC-CMs and were able to reduce episodes of stress-induced ventricular tachycardia in mice and reduce arrhythmogenic Ca<sup>2+</sup> waves in iPSC-CMs [<a href="#B87-biomedicines-11-00334" class="usa-link" aria-describedby="B87-biomedicines-11-00334">87</a>]. Two other MiCUps, ezetimibe and disulfiram, suppressed arrhythmogenesis in patient iPSC-CMs [<a href="#B88-biomedicines-11-00334" class="usa-link" aria-describedby="B88-biomedicines-11-00334">88</a>] (genetic variant not specified). Another way to modulate calcium is by inhibiting the Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) with a CaMKII inhibitory peptide, which is successful in reducing the abnormal Ca<sup>2+</sup> release events and frequency of Ca<sup>2+</sup> sparks in two CPVT <em>RYR2</em> (p.(Ser404Arg)/p.(Asn658Ser), p.(Gly3946Ser)/(p.(Gly1885Glu)) iPSC-CMs [<a href="#B89-biomedicines-11-00334" class="usa-link" aria-describedby="B89-biomedicines-11-00334">89</a>]. EL20, a tetracaine derivative and <em>RYR2</em> inhibitor, decreased spark activity in iPSC-CMs of a CPVT patient harbouring a <em>RYR2</em> (p.(Arg176Gln)) mutation without negatively affecting the Ca<sup>2+</sup> transient amplitude [<a href="#B24-biomedicines-11-00334" class="usa-link" aria-describedby="B24-biomedicines-11-00334">24</a>]. Stutzman et al. created four iPSC-CM lines of CPVT patients with <em>RYR2</em> mutations, (p.(Phe13Leu), p.(Leu14Pro), p.(Arg15Pro) and p.(Arg176Gln)), and treated them with nadolol and flecainide. Both were able to decrease the Ca<sup>2+</sup> transient amplitude and spark activity [<a href="#B26-biomedicines-11-00334" class="usa-link" aria-describedby="B26-biomedicines-11-00334">26</a>].</p>
<p>All these reports confirm the great potential of iPSC-CM arrhythmia models to test novel and existing therapies, and also for personalised medicine. In both 2D and 3D, they could also be effectively used for larger drug-library screening experiments.</p></section><section id="sec4dot3-biomedicines-11-00334"><h3 class="pmc_sec_title">4.3. Gene Therapy Testing</h3>
<p>Inherited cardiac arrhythmia iPSC-CM models have also been used to test novel gene therapies, acting straight on the nucleic acid molecular/genetic level.</p>
<p>One way to perform gene therapy is by patient-specific targeting the causal mutation. Matsa et al. used an allele-specific small interfering RNA to knock down the mutated <em>KCNH2</em> mRNA in LQTS (<em>KCNH2</em> p.(Ala561Thr)) patient iPSC-CMs thereby preventing the dominant negative-trafficking defect. This resulted in a shortening of the AP, increase in K<sup>+</sup> current and rescue of the arrhythmogenic phenotype [<a href="#B92-biomedicines-11-00334" class="usa-link" aria-describedby="B92-biomedicines-11-00334">92</a>]. A more general gene therapy approach was published by Dotzler et al. They developed a novel method with a dual mode of action called suppression-and-replacement (SupRep) <em>KCNQ1</em> gene therapy. As the name indicates, first the endogenous alleles were suppressed by short hairpin RNA (shRNA) and in the next step, the <em>KCNQ1</em> gene was replaced by expression of a shRNA-immune (shIMM) <em>KCNQ1</em> cDNA immune for breakdown by the shRNA. This method was tested in four LQT1 (<em>KCNQ1</em> p.(Tyr171X), p.(Val254Met), p.(Ile567Ser) and p.(Ala344Ala/splice variant)) patient iPSC-CM models and showed a shortening of the APD in all 2D patient models. As a proof-of-concept, a 3D cardiac organoid of one of the patient lines (p.(Tyr171X)) was created and here as well, an APD shortening was observed after treatment [<a href="#B93-biomedicines-11-00334" class="usa-link" aria-describedby="B93-biomedicines-11-00334">93</a>]. The same treatment approach was used for <em>KCNH2</em> variants, in iPSC-CM models of two LQT2 (p.(Gly604Ser), p.(Asn633Ser)) patients as well as in one SQT (p.(Asn588Lys) patient and resulted in a normal APD90 for both the LQT2 and SQT patients [<a href="#B94-biomedicines-11-00334" class="usa-link" aria-describedby="B94-biomedicines-11-00334">94</a>].</p></section></section><section id="sec5-biomedicines-11-00334"><h2 class="pmc_sec_title">5. Discussion and Conclusions</h2>
<p>With the advent of iPSC creation, major steps have been taken to differentiate these stem cells into several cell types including iPSC-derived cardiomyocytes. Using this model in inherited cardiac arrhythmia research has increased knowledge on the underlying disease mechanisms and creates opportunities to functionally characterise and interpret the pathogenicity of patient-specific genetic variants and to perform (personalised) drug testing. As a proof-of-concept of this more ‘personalised’ drug testing, a few ‘clinical trials in a dish’ have been performed where healthy control individuals and their iPSC-CMs were challenged with known QT-prolonging drugs to compare the effect on the in vitro model to the in vivo situation. Using sotalol, a correlation was found between the in vivo QT interval and in vitro FPD results [<a href="#B95-biomedicines-11-00334" class="usa-link" aria-describedby="B95-biomedicines-11-00334">95</a>]. One study also found such a positive correlation for moxifloxacin [<a href="#B96-biomedicines-11-00334" class="usa-link" aria-describedby="B96-biomedicines-11-00334">96</a>] while another did not find a correlation between the APD response slopes and clinical QT response to moxifloxacin or dofetilide [<a href="#B97-biomedicines-11-00334" class="usa-link" aria-describedby="B97-biomedicines-11-00334">97</a>]. Using (subject-specific) iPSCs for research and drug testing also requires the use of a comprehensive informed consent explaining future use of created iPSCs and derivatives. The reported 2D iPSC-CM disease models recapitulate the patients’ phenotype at the cellular level, however, if the specific tested characteristics are compared over several iPSC-clones or several different papers, quite some variability can be observed [<a href="#B98-biomedicines-11-00334" class="usa-link" aria-describedby="B98-biomedicines-11-00334">98</a>]. In addition, for example, the iPSC-CM models of BrS patients with an unknown genetic cause did not show any electrophysiological differences compared to healthy control iPSC-CMs [<a href="#B99-biomedicines-11-00334" class="usa-link" aria-describedby="B99-biomedicines-11-00334">99</a>]. The known immature phenotype of iPSC-CMs with immature ion channel expression most likely plays a role in these observations and small changes in ionic currents might not be picked up. More in-depth analysis of the iPSC-CM cellular disease phenotype including transcriptomics or proteomics approaches could be useful to further characterise these models.</p>
<p>In addition, efforts have been made to improve the maturity of iPSC-CMs, with one important strategy to culture them in 3D models such as microtissues, organoids and engineered heart tissue. Amongst others, Kerr et al. showed that iPSC-CM in 3D cultures showed a higher similarity to human adult myocardial transcriptome compared to 2D models and had enhanced cell–cell communication, ECM organisation and vascularisation capacity [<a href="#B100-biomedicines-11-00334" class="usa-link" aria-describedby="B100-biomedicines-11-00334">100</a>]. The addition of other (iPSC-derived) cell types that are present in heart tissue further improves the physiological relevance and maturation state of the model. Use of these 3D models will certainly increase the suitability for disease modelling and drug testing. It should be taken into account, though, that they are more complex at the culture level—complicating the high-throughput needed for larger screenings, so that extra variability is introduced to an already variable model [<a href="#B98-biomedicines-11-00334" class="usa-link" aria-describedby="B98-biomedicines-11-00334">98</a>] and the complexity of the analysis is also increased. Light for microscopy, fluorescent dyes and drugs need to penetrate deeper and evenly into the 3D culture to reach all cells, more computational power might be needed and more expensive single-cell analysis approaches such as scRNA-seq could be necessary. Indeed, Feng et al. already performed single cell analysis on cardiac organoids and found more differentially expressed genes in iPSC-CMs compared to other cell types present in the organoid between Ebstein’s anomaly patients and healthy controls [<a href="#B101-biomedicines-11-00334" class="usa-link" aria-describedby="B101-biomedicines-11-00334">101</a>].</p>
<p>Despite the immense progress that has been made in iPSC-CM generation and application potential, some limiting factors such as immaturity, genetic and phenotypic heterogeneity and variability still have an impact on their usability and should be kept in mind when translating the results in vivo [<a href="#B98-biomedicines-11-00334" class="usa-link" aria-describedby="B98-biomedicines-11-00334">98</a>]. For clinical application in regenerative medicine the arrhythmogenic potential, immunogenicity, tumorigenicity and heterogeneity of the iPSC-CMs should be taken into consideration. In conclusion, iPSC-CMs have been instrumental in modelling inherited cardiac arrhythmias, small-scale testing of disease-specific drugs or gene therapies and cardiotoxicity testing. The transition from 2D to 3D models has improved cellular maturity and physiological relevance, but also increases the complexity of the model and its analysis. Large-scale drug library screenings have not yet been performed, but further automation and high-throughput analysis methods will certainly pave the way for this application. Further evolution of both 2D and 3D iPSC-CM modelling and analysis techniques will allow the discovery of new treatment options for cardiac arrhythmias in general as well as for personalised medicine.</p></section><section id="app1-biomedicines-11-00334" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online at <a href="https://www.mdpi.com/article/10.3390/biomedicines11020334/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/biomedicines11020334/s1</a>, Table S1: overview of previously published 2D iPSC-CM cardiac arrhythmia disease models. References [<a href="#B102-biomedicines-11-00334" class="usa-link" aria-describedby="B102-biomedicines-11-00334">102</a>,<a href="#B103-biomedicines-11-00334" class="usa-link" aria-describedby="B103-biomedicines-11-00334">103</a>,<a href="#B104-biomedicines-11-00334" class="usa-link" aria-describedby="B104-biomedicines-11-00334">104</a>,<a href="#B105-biomedicines-11-00334" class="usa-link" aria-describedby="B105-biomedicines-11-00334">105</a>,<a href="#B106-biomedicines-11-00334" class="usa-link" aria-describedby="B106-biomedicines-11-00334">106</a>,<a href="#B107-biomedicines-11-00334" class="usa-link" aria-describedby="B107-biomedicines-11-00334">107</a>,<a href="#B108-biomedicines-11-00334" class="usa-link" aria-describedby="B108-biomedicines-11-00334">108</a>,<a href="#B109-biomedicines-11-00334" class="usa-link" aria-describedby="B109-biomedicines-11-00334">109</a>,<a href="#B110-biomedicines-11-00334" class="usa-link" aria-describedby="B110-biomedicines-11-00334">110</a>,<a href="#B111-biomedicines-11-00334" class="usa-link" aria-describedby="B111-biomedicines-11-00334">111</a>,<a href="#B112-biomedicines-11-00334" class="usa-link" aria-describedby="B112-biomedicines-11-00334">112</a>,<a href="#B113-biomedicines-11-00334" class="usa-link" aria-describedby="B113-biomedicines-11-00334">113</a>,<a href="#B114-biomedicines-11-00334" class="usa-link" aria-describedby="B114-biomedicines-11-00334">114</a>,<a href="#B115-biomedicines-11-00334" class="usa-link" aria-describedby="B115-biomedicines-11-00334">115</a>,<a href="#B116-biomedicines-11-00334" class="usa-link" aria-describedby="B116-biomedicines-11-00334">116</a>,<a href="#B117-biomedicines-11-00334" class="usa-link" aria-describedby="B117-biomedicines-11-00334">117</a>,<a href="#B118-biomedicines-11-00334" class="usa-link" aria-describedby="B118-biomedicines-11-00334">118</a>,<a href="#B119-biomedicines-11-00334" class="usa-link" aria-describedby="B119-biomedicines-11-00334">119</a>,<a href="#B120-biomedicines-11-00334" class="usa-link" aria-describedby="B120-biomedicines-11-00334">120</a>,<a href="#B121-biomedicines-11-00334" class="usa-link" aria-describedby="B121-biomedicines-11-00334">121</a>,<a href="#B122-biomedicines-11-00334" class="usa-link" aria-describedby="B122-biomedicines-11-00334">122</a>,<a href="#B123-biomedicines-11-00334" class="usa-link" aria-describedby="B123-biomedicines-11-00334">123</a>,<a href="#B124-biomedicines-11-00334" class="usa-link" aria-describedby="B124-biomedicines-11-00334">124</a>,<a href="#B125-biomedicines-11-00334" class="usa-link" aria-describedby="B125-biomedicines-11-00334">125</a>,<a href="#B126-biomedicines-11-00334" class="usa-link" aria-describedby="B126-biomedicines-11-00334">126</a>,<a href="#B127-biomedicines-11-00334" class="usa-link" aria-describedby="B127-biomedicines-11-00334">127</a>,<a href="#B128-biomedicines-11-00334" class="usa-link" aria-describedby="B128-biomedicines-11-00334">128</a>] are cited.</p>
<section class="sm xbox font-sm" id="biomedicines-11-00334-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/9953535/bin/biomedicines-11-00334-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (142.7KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, E.S., M.A. and B.L.; Writing—original draft, E.S.; writing—review and editing, E.S., M.A. and B.L. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>E. Simons is a research fellow supported by the Research Foundation—Flanders (FWO, Belgium, 1S25318N). Dr. Loeys holds a consolidator grant from the European Research Council (“Genomia” ERC-COG-2017-771945). This research was largely supported by funding from the University of Antwerp (GOA 33933; Methusalem-OEC grant “Genomed” 40709) and the Research Foundation Flanders (FWO, Belgium, G042321N, G040221N, G044720N).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Disclaimer/Publisher’s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-biomedicines-11-00334">
<span class="label">1.</span><cite>Takahashi K., Yamanaka S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024.</cite> [<a href="https://doi.org/10.1016/j.cell.2006.07.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16904174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Induction%20of%20Pluripotent%20Stem%20Cells%20from%20Mouse%20Embryonic%20and%20Adult%20Fibroblast%20Cultures%20by%20Defined%20Factors&amp;author=K.%20Takahashi&amp;author=S.%20Yamanaka&amp;volume=126&amp;publication_year=2006&amp;pages=663-676&amp;pmid=16904174&amp;doi=10.1016/j.cell.2006.07.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-biomedicines-11-00334">
<span class="label">2.</span><cite>Iannielli A., Luoni M., Giannelli S.G., Ferese R., Ordazzo G., Fossati M., Raimondi A., Opazo F., Corti O., Prehn J.H.M., et al.  Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications. Cell Death Dis. 2022;13:881. doi: 10.1038/s41419-022-05330-6.</cite> [<a href="https://doi.org/10.1038/s41419-022-05330-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9581971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36261424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis.&amp;title=Modeling%20native%20and%20seeded%20Synuclein%20aggregation%20and%20related%20cellular%20dysfunctions%20in%20dopaminergic%20neurons%20derived%20by%20a%20new%20set%20of%20isogenic%20iPSC%20lines%20with%20SNCA%20multiplications&amp;author=A.%20Iannielli&amp;author=M.%20Luoni&amp;author=S.G.%20Giannelli&amp;author=R.%20Ferese&amp;author=G.%20Ordazzo&amp;volume=13&amp;publication_year=2022&amp;pages=881&amp;pmid=36261424&amp;doi=10.1038/s41419-022-05330-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-biomedicines-11-00334">
<span class="label">3.</span><cite>Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I.-H., Gepstein L. Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells. Circulation. 2009;120:1513–1523. doi: 10.1161/CIRCULATIONAHA.109.868885.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.109.868885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19786631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Cardiomyocyte%20Differentiation%20of%20Human%20Induced%20Pluripotent%20Stem%20Cells&amp;author=L.%20Zwi&amp;author=O.%20Caspi&amp;author=G.%20Arbel&amp;author=I.%20Huber&amp;author=A.%20Gepstein&amp;volume=120&amp;publication_year=2009&amp;pages=1513-1523&amp;pmid=19786631&amp;doi=10.1161/CIRCULATIONAHA.109.868885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-biomedicines-11-00334">
<span class="label">4.</span><cite>Lai X., Li C., Xiang C., Pan Z., Zhang K., Wang L., Xie B., Cao J., Shi J., Deng J., et al.  Generation of functionally competent hepatic stellate cells from human stem cells to model liver fibrosis in vitro. Stem Cell Rep. 2022;17:2531–2547. doi: 10.1016/j.stemcr.2022.09.010.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2022.09.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9669405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36270282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Rep.&amp;title=Generation%20of%20functionally%20competent%20hepatic%20stellate%20cells%20from%20human%20stem%20cells%20to%20model%20liver%20fibrosis%20in%20vitro&amp;author=X.%20Lai&amp;author=C.%20Li&amp;author=C.%20Xiang&amp;author=Z.%20Pan&amp;author=K.%20Zhang&amp;volume=17&amp;publication_year=2022&amp;pages=2531-2547&amp;pmid=36270282&amp;doi=10.1016/j.stemcr.2022.09.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-biomedicines-11-00334">
<span class="label">5.</span><cite>Casini S., Verkerk A.O., Remme C.A. Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations. Cardiovasc. Drugs Ther. 2017;31:325–344. doi: 10.1007/s10557-017-6735-0.</cite> [<a href="https://doi.org/10.1007/s10557-017-6735-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5550530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28721524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Drugs%20Ther.&amp;title=Human%20iPSC-Derived%20Cardiomyocytes%20for%20Investigation%20of%20Disease%20Mechanisms%20and%20Therapeutic%20Strategies%20in%20Inherited%20Arrhythmia%20Syndromes:%20Strengths%20and%20Limitations&amp;author=S.%20Casini&amp;author=A.O.%20Verkerk&amp;author=C.A.%20Remme&amp;volume=31&amp;publication_year=2017&amp;pages=325-344&amp;pmid=28721524&amp;doi=10.1007/s10557-017-6735-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-biomedicines-11-00334">
<span class="label">6.</span><cite>Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flügel L., Dorn T., Goedel A., Höhnke C., Hofmann F., et al.  Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome. N. Engl. J. Med. 2010;363:1397–1409. doi: 10.1056/NEJMoa0908679.</cite> [<a href="https://doi.org/10.1056/NEJMoa0908679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20660394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Patient-Specific%20Induced%20Pluripotent%20Stem-Cell%20Models%20for%20Long-QT%20Syndrome&amp;author=A.%20Moretti&amp;author=M.%20Bellin&amp;author=A.%20Welling&amp;author=C.B.%20Jung&amp;author=J.T.%20Lam&amp;volume=363&amp;publication_year=2010&amp;pages=1397-1409&amp;pmid=20660394&amp;doi=10.1056/NEJMoa0908679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-biomedicines-11-00334">
<span class="label">7.</span><cite>Rajamohan D., Kalra S., Hoang M.D., George V., Staniforth A., Russell H., Yang X., Denning C. Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells Dev. 2016;25:439–452. doi: 10.1089/scd.2015.0253.</cite> [<a href="https://doi.org/10.1089/scd.2015.0253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4790208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26906236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells%20Dev.&amp;title=Automated%20Electrophysiological%20and%20Pharmacological%20Evaluation%20of%20Human%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=D.%20Rajamohan&amp;author=S.%20Kalra&amp;author=M.D.%20Hoang&amp;author=V.%20George&amp;author=A.%20Staniforth&amp;volume=25&amp;publication_year=2016&amp;pages=439-452&amp;pmid=26906236&amp;doi=10.1089/scd.2015.0253&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-biomedicines-11-00334">
<span class="label">8.</span><cite>Protze S.I., Lee J.H., Keller G.M. Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications. Cell Stem Cell. 2019;25:311–327. doi: 10.1016/j.stem.2019.07.010.</cite> [<a href="https://doi.org/10.1016/j.stem.2019.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31491395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Human%20Pluripotent%20Stem%20Cell-Derived%20Cardiovascular%20Cells:%20From%20Developmental%20Biology%20to%20Therapeutic%20Applications&amp;author=S.I.%20Protze&amp;author=J.H.%20Lee&amp;author=G.M.%20Keller&amp;volume=25&amp;publication_year=2019&amp;pages=311-327&amp;pmid=31491395&amp;doi=10.1016/j.stem.2019.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-biomedicines-11-00334">
<span class="label">9.</span><cite>Garg P., Garg V., Shrestha R., Sanguinetti M.C., Kamp T.J., Wu J.C. Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies. Circ. Res. 2018;123:224–243. doi: 10.1161/CIRCRESAHA.118.311209.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.118.311209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6136439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29976690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Human%20Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes%20as%20Models%20for%20Cardiac%20Channelopathies&amp;author=P.%20Garg&amp;author=V.%20Garg&amp;author=R.%20Shrestha&amp;author=M.C.%20Sanguinetti&amp;author=T.J.%20Kamp&amp;volume=123&amp;publication_year=2018&amp;pages=224-243&amp;pmid=29976690&amp;doi=10.1161/CIRCRESAHA.118.311209&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-biomedicines-11-00334">
<span class="label">10.</span><cite>Pan Z., Ebert A., Liang P. Human-induced pluripotent stem cells as models for rare cardiovascular diseases: From evidence-based medicine to precision medicine. Pflugers Arch. 2021;473:1151–1165. doi: 10.1007/s00424-020-02486-y.</cite> [<a href="https://doi.org/10.1007/s00424-020-02486-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33206225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pflugers%20Arch.&amp;title=Human-induced%20pluripotent%20stem%20cells%20as%20models%20for%20rare%20cardiovascular%20diseases:%20From%20evidence-based%20medicine%20to%20precision%20medicine&amp;author=Z.%20Pan&amp;author=A.%20Ebert&amp;author=P.%20Liang&amp;volume=473&amp;publication_year=2021&amp;pages=1151-1165&amp;pmid=33206225&amp;doi=10.1007/s00424-020-02486-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-biomedicines-11-00334">
<span class="label">11.</span><cite>Garg P., Oikonomopoulos A., Chen H., Li Y., Lam C.K., Sallam K., Perez M., Lux R.L., Sanguinetti M.C., Wu J.C. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. J. Am. Coll. Cardiol. 2018;72:62–75. doi: 10.1016/j.jacc.2018.04.041.</cite> [<a href="https://doi.org/10.1016/j.jacc.2018.04.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6050025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29957233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Genome%20Editing%20of%20Induced%20Pluripotent%20Stem%20Cells%20to%20Decipher%20Cardiac%20Channelopathy%20Variant&amp;author=P.%20Garg&amp;author=A.%20Oikonomopoulos&amp;author=H.%20Chen&amp;author=Y.%20Li&amp;author=C.K.%20Lam&amp;volume=72&amp;publication_year=2018&amp;pages=62-75&amp;pmid=29957233&amp;doi=10.1016/j.jacc.2018.04.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-biomedicines-11-00334">
<span class="label">12.</span><cite>Chavali N.V., Kryshtal D.O., Parikh S.S., Wang L., Glazer A.M., Blackwell D.J., Kroncke B.M., Shoemaker M.B., Knollmann B.C. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome. Heart Rhythm. 2019;16:1686–1695. doi: 10.1016/j.hrthm.2019.04.031.</cite> [<a href="https://doi.org/10.1016/j.hrthm.2019.04.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6935564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31004778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm.&amp;title=Patient-independent%20human%20induced%20pluripotent%20stem%20cell%20model:%20A%20new%20tool%20for%20rapid%20determination%20of%20genetic%20variant%20pathogenicity%20in%20long%20QT%20syndrome&amp;author=N.V.%20Chavali&amp;author=D.O.%20Kryshtal&amp;author=S.S.%20Parikh&amp;author=L.%20Wang&amp;author=A.M.%20Glazer&amp;volume=16&amp;publication_year=2019&amp;pages=1686-1695&amp;pmid=31004778&amp;doi=10.1016/j.hrthm.2019.04.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-biomedicines-11-00334">
<span class="label">13.</span><cite>Davis R.P., Casini S., Berg C.W.V.D., Hoekstra M., Remme C.A., Dambrot C., Salvatori D., Oostwaard D.W.-V., Wilde A.A.M., Bezzina C.R., et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease. Circulation. 2012;125:3079–3091. doi: 10.1161/CIRCULATIONAHA.111.066092.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.111.066092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22647976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Cardiomyocytes%20Derived%20From%20Pluripotent%20Stem%20Cells%20Recapitulate%20Electrophysiological%20Characteristics%20of%20an%20Overlap%20Syndrome%20of%20Cardiac%20Sodium%20Channel%20Disease&amp;author=R.P.%20Davis&amp;author=S.%20Casini&amp;author=C.W.V.D.%20Berg&amp;author=M.%20Hoekstra&amp;author=C.A.%20Remme&amp;volume=125&amp;publication_year=2012&amp;pages=3079-3091&amp;pmid=22647976&amp;doi=10.1161/CIRCULATIONAHA.111.066092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-biomedicines-11-00334">
<span class="label">14.</span><cite>Liang P., Sallam K., Wu H., Li Y., Itzhaki I., Garg P., Zhang Y., Termglichan V., Lan F., Gu M., et al.  Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell–Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome. J. Am. Coll. Cardiol. 2016;68:2086–2096. doi: 10.1016/j.jacc.2016.07.779.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.07.779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5373649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27810048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Patient-Specific%20and%20Genome-Edited%20Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes%20Elucidate%20Single-Cell%20Phenotype%20of%20Brugada%20Syndrome&amp;author=P.%20Liang&amp;author=K.%20Sallam&amp;author=H.%20Wu&amp;author=Y.%20Li&amp;author=I.%20Itzhaki&amp;volume=68&amp;publication_year=2016&amp;pages=2086-2096&amp;pmid=27810048&amp;doi=10.1016/j.jacc.2016.07.779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-biomedicines-11-00334">
<span class="label">15.</span><cite>Zhong R., Schimanski T., Zhang F., Lan H., Hohn A., Xu Q., Huang M., Liao Z., Qiao L., Yang Z., et al.  A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. Int. J. Mol. Sci. 2022;23:8313.  doi: 10.3390/ijms23158313.</cite> [<a href="https://doi.org/10.3390/ijms23158313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9368582/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35955449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=A%20Preclinical%20Study%20on%20Brugada%20Syndrome%20with%20a%20CACNB2%20Variant%20Using%20Human%20Cardiomyocytes%20from%20Induced%20Pluripotent%20Stem%20Cells&amp;author=R.%20Zhong&amp;author=T.%20Schimanski&amp;author=F.%20Zhang&amp;author=H.%20Lan&amp;author=A.%20Hohn&amp;volume=23&amp;publication_year=2022&amp;pages=8313&amp;pmid=35955449&amp;doi=10.3390/ijms23158313&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-biomedicines-11-00334">
<span class="label">16.</span><cite>Zhu Y., Wang L., Cui C., Qin H., Chen H., Chen S., Lin Y., Cheng H., Jiang X., Chen M. Pathogenesis and drug response of iPSC-derived cardiomyocytes from two Brugada syndrome patients with different Nav1.5-subunit mutations. J. Biomed. Res. 2021;35:395. doi: 10.7555/JBR.35.20210045.</cite> [<a href="https://doi.org/10.7555/JBR.35.20210045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8502687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34628405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomed.%20Res.&amp;title=Pathogenesis%20and%20drug%20response%20of%20iPSC-derived%20cardiomyocytes%20from%20two%20Brugada%20syndrome%20patients%20with%20different%20Nav1.5-subunit%20mutations&amp;author=Y.%20Zhu&amp;author=L.%20Wang&amp;author=C.%20Cui&amp;author=H.%20Qin&amp;author=H.%20Chen&amp;volume=35&amp;publication_year=2021&amp;pages=395&amp;pmid=34628405&amp;doi=10.7555/JBR.35.20210045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-biomedicines-11-00334">
<span class="label">17.</span><cite>Li W., Stauske M., Luo X., Wagner S., Vollrath M., Mehnert C.S., Schubert M., Cyganek L., Chen S., Hasheminasab S.-M., et al.  Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation. Front. Cell Dev. Biol. 2020;8:592893. doi: 10.3389/fcell.2020.592893.</cite> [<a href="https://doi.org/10.3389/fcell.2020.592893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7642519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33195263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell%20Dev.%20Biol.&amp;title=Disease%20Phenotypes%20and%20Mechanisms%20of%20iPSC-Derived%20Cardiomyocytes%20From%20Brugada%20Syndrome%20Patients%20With%20a%20Loss-of-Function%20SCN5A%20Mutation&amp;author=W.%20Li&amp;author=M.%20Stauske&amp;author=X.%20Luo&amp;author=S.%20Wagner&amp;author=M.%20Vollrath&amp;volume=8&amp;publication_year=2020&amp;pages=592893&amp;pmid=33195263&amp;doi=10.3389/fcell.2020.592893&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-biomedicines-11-00334">
<span class="label">18.</span><cite>El-Battrawy I., Lan H., Cyganek L., Zhao Z., Li X., Buljubasic F., Lang S., Yücel G., Sattler K., Zimmermann W., et al.  Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes. J. Am. Heart Assoc. 2018;7:e007394. doi: 10.1161/JAHA.117.007394.</cite> [<a href="https://doi.org/10.1161/JAHA.117.007394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5907581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29574456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=Modeling%20Short%20QT%20Syndrome%20Using%20Human-Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes&amp;author=I.%20El-Battrawy&amp;author=H.%20Lan&amp;author=L.%20Cyganek&amp;author=Z.%20Zhao&amp;author=X.%20Li&amp;volume=7&amp;publication_year=2018&amp;pages=e007394&amp;pmid=29574456&amp;doi=10.1161/JAHA.117.007394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-biomedicines-11-00334">
<span class="label">19.</span><cite>Shinnawi R., Shaheen N., Huber I., Shiti A., Arbel G., Gepstein A., Ballan N., Setter N., Tijsen A.J., Borggrefe M., et al.  Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell–Derived Cardiac Cell Sheets. J. Am. Coll. Cardiol. 2019;73:2310–2324. doi: 10.1016/j.jacc.2019.02.055.</cite> [<a href="https://doi.org/10.1016/j.jacc.2019.02.055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31072576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Modeling%20Reentry%20in%20the%20Short%20QT%20Syndrome%20With%20Human-Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiac%20Cell%20Sheets&amp;author=R.%20Shinnawi&amp;author=N.%20Shaheen&amp;author=I.%20Huber&amp;author=A.%20Shiti&amp;author=G.%20Arbel&amp;volume=73&amp;publication_year=2019&amp;pages=2310-2324&amp;pmid=31072576&amp;doi=10.1016/j.jacc.2019.02.055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-biomedicines-11-00334">
<span class="label">20.</span><cite>Guo F., Sun Y., Wang X., Wang H., Wang J., Gong T., Chen X., Zhang P., Su L., Fu G., et al.  Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome. Circ. Res. 2019;124:66–78. doi: 10.1161/CIRCRESAHA.118.313518.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.118.313518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30582453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Patient-Specific%20and%20Gene-Corrected%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20Elucidate%20Single-Cell%20Phenotype%20of%20Short%20QT%20Syndrome&amp;author=F.%20Guo&amp;author=Y.%20Sun&amp;author=X.%20Wang&amp;author=H.%20Wang&amp;author=J.%20Wang&amp;volume=124&amp;publication_year=2019&amp;pages=66-78&amp;pmid=30582453&amp;doi=10.1161/CIRCRESAHA.118.313518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-biomedicines-11-00334">
<span class="label">21.</span><cite>Fatima A., Xu G., Shao K., Papadopoulos S., Lehmann M., Arnáiz-Cot J.J., Rosa A.O., Nguemo F., Matzkies M., Dittmann S., et al.  In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells. Cell. Physiol. Biochem. 2011;28:579–592. doi: 10.1159/000335753.</cite> [<a href="https://doi.org/10.1159/000335753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3709175/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22178870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell.%20Physiol.%20Biochem.&amp;title=In%20vitro%20Modeling%20of%20Ryanodine%20Receptor%202%20Dysfunction%20Using%20Human%20Induced%20Pluripotent%20Stem%20Cells&amp;author=A.%20Fatima&amp;author=G.%20Xu&amp;author=K.%20Shao&amp;author=S.%20Papadopoulos&amp;author=M.%20Lehmann&amp;volume=28&amp;publication_year=2011&amp;pages=579-592&amp;pmid=22178870&amp;doi=10.1159/000335753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-biomedicines-11-00334">
<span class="label">22.</span><cite>Wei H., Zhang X.-H., Clift C., Yamaguchi N., Morad M. CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling. Cell Calcium. 2018;73:104–111. doi: 10.1016/j.ceca.2018.04.009.</cite> [<a href="https://doi.org/10.1016/j.ceca.2018.04.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5993620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29730419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Calcium&amp;title=CRISPR/Cas9%20Gene%20editing%20of%20RyR2%20in%20human%20stem%20cell-derived%20cardiomyocytes%20provides%20a%20novel%20approach%20in%20investigating%20dysfunctional%20Ca2+%20signaling&amp;author=H.%20Wei&amp;author=X.-H.%20Zhang&amp;author=C.%20Clift&amp;author=N.%20Yamaguchi&amp;author=M.%20Morad&amp;volume=73&amp;publication_year=2018&amp;pages=104-111&amp;pmid=29730419&amp;doi=10.1016/j.ceca.2018.04.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-biomedicines-11-00334">
<span class="label">23.</span><cite>Acimovic I., Refaat M.M., Moreau A., Salykin A., Reiken S., Sleiman Y., Souidi M., Přibyl J., Kajava A.V., Richard S., et al.  Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes. J. Clin. Med. 2018;7:423.  doi: 10.3390/jcm7110423.</cite> [<a href="https://doi.org/10.3390/jcm7110423" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6262462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30413023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Post-Translational%20Modifications%20and%20Diastolic%20Calcium%20Leak%20Associated%20to%20the%20Novel%20RyR2-D3638A%20Mutation%20Lead%20to%20CPVT%20in%20Patient-Specific%20hiPSC-Derived%20Cardiomyocytes&amp;author=I.%20Acimovic&amp;author=M.M.%20Refaat&amp;author=A.%20Moreau&amp;author=A.%20Salykin&amp;author=S.%20Reiken&amp;volume=7&amp;publication_year=2018&amp;pages=423&amp;pmid=30413023&amp;doi=10.3390/jcm7110423&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-biomedicines-11-00334">
<span class="label">24.</span><cite>Word T.A., Quick A.P., Miyake C.Y., Shak M.K., Pan X., Kim J.J., Allen H.D., Sibrian-Vazquez M., Strongin R.M., Landstrom A.P., et al.  Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia. J. Cell. Mol. Med. 2021;25:6115–6124. doi: 10.1111/jcmm.16521.</cite> [<a href="https://doi.org/10.1111/jcmm.16521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8366453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34110090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell.%20Mol.%20Med.&amp;title=Efficacy%20of%20RyR2%20inhibitor%20EL20%20in%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20from%20a%20patient%20with%20catecholaminergic%20polymorphic%20ventricular%20tachycardia&amp;author=T.A.%20Word&amp;author=A.P.%20Quick&amp;author=C.Y.%20Miyake&amp;author=M.K.%20Shak&amp;author=X.%20Pan&amp;volume=25&amp;publication_year=2021&amp;pages=6115-6124&amp;pmid=34110090&amp;doi=10.1111/jcmm.16521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-biomedicines-11-00334">
<span class="label">25.</span><cite>Zhang X.-H., Wei H., Xia Y., Morad M. Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R. Heart Rhythm. 2021;18:250–260. doi: 10.1016/j.hrthm.2020.09.007.</cite> [<a href="https://doi.org/10.1016/j.hrthm.2020.09.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7893824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32931925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm.&amp;title=Calcium%20signaling%20consequences%20of%20RyR2%20mutations%20associated%20with%20CPVT1%20introduced%20via%20CRISPR/Cas9%20gene%20editing%20in%20human-induced%20pluripotent%20stem%20cell%E2%80%93derived%20cardiomyocytes:%20Comparison%20of%20RyR2-R420Q,%20F2483I,%20and%20Q4201R&amp;author=X.-H.%20Zhang&amp;author=H.%20Wei&amp;author=Y.%20Xia&amp;author=M.%20Morad&amp;volume=18&amp;publication_year=2021&amp;pages=250-260&amp;pmid=32931925&amp;doi=10.1016/j.hrthm.2020.09.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-biomedicines-11-00334">
<span class="label">26.</span><cite>Stutzman M.J., Kim C.J., Tester D.J., Hamrick S.K., Dotzler S.M., Giudicessi J.R., Miotto M.C., Gc J.B., Frank J., Marks A.R., et al.  Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential. Stem Cell Rep. 2022;17:2023–2036. doi: 10.1016/j.stemcr.2022.07.002.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2022.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9481874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35931078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Rep.&amp;title=Characterization%20of%20N-terminal%20RYR2%20variants%20outside%20CPVT1%20hotspot%20regions%20using%20patient%20iPSCs%20reveal%20pathogenesis%20and%20therapeutic%20potential&amp;author=M.J.%20Stutzman&amp;author=C.J.%20Kim&amp;author=D.J.%20Tester&amp;author=S.K.%20Hamrick&amp;author=S.M.%20Dotzler&amp;volume=17&amp;publication_year=2022&amp;pages=2023-2036&amp;pmid=35931078&amp;doi=10.1016/j.stemcr.2022.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-biomedicines-11-00334">
<span class="label">27.</span><cite>Novak A., Barad L., Zeevi-Levin N., Shick R., Shtrichman R., Lorber A., Itskovitz-Eldor J., Binah O. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation. J. Cell. Mol. Med. 2012;16:468–482. doi: 10.1111/j.1582-4934.2011.01476.x.</cite> [<a href="https://doi.org/10.1111/j.1582-4934.2011.01476.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3822924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22050625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell.%20Mol.%20Med.&amp;title=Cardiomyocytes%20generated%20from%20CPVTD307H%20patients%20are%20arrhythmogenic%20in%20response%20to%20%CE%B2-adrenergic%20stimulation&amp;author=A.%20Novak&amp;author=L.%20Barad&amp;author=N.%20Zeevi-Levin&amp;author=R.%20Shick&amp;author=R.%20Shtrichman&amp;volume=16&amp;publication_year=2012&amp;pages=468-482&amp;pmid=22050625&amp;doi=10.1111/j.1582-4934.2011.01476.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-biomedicines-11-00334">
<span class="label">28.</span><cite>Ma D., Wei H., Lu J., Ho S., Zhang G., Sun X., Oh Y., Tan S.H., Ng M.L., Shim W., et al.  Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2013;34:1122–1133. doi: 10.1093/eurheartj/ehs226.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehs226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22798562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Generation%20of%20patient-specific%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20as%20a%20cellular%20model%20of%20arrhythmogenic%20right%20ventricular%20cardiomyopathy&amp;author=D.%20Ma&amp;author=H.%20Wei&amp;author=J.%20Lu&amp;author=S.%20Ho&amp;author=G.%20Zhang&amp;volume=34&amp;publication_year=2013&amp;pages=1122-1133&amp;pmid=22798562&amp;doi=10.1093/eurheartj/ehs226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-biomedicines-11-00334">
<span class="label">29.</span><cite>El-Battrawy I., Zhao Z., Lan H., Cyganek L., Tombers C., Li X., Buljubasic F., Lang S., Tiburcy M., Zimmermann W.-H., et al.  Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. Europace. 2018;20:f46–f56. doi: 10.1093/europace/euy042.</cite> [<a href="https://doi.org/10.1093/europace/euy042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29566126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Electrical%20dysfunctions%20in%20human-induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20from%20a%20patient%20with%20an%20arrhythmogenic%20right%20ventricular%20cardiomyopathy&amp;author=I.%20El-Battrawy&amp;author=Z.%20Zhao&amp;author=H.%20Lan&amp;author=L.%20Cyganek&amp;author=C.%20Tombers&amp;volume=20&amp;publication_year=2018&amp;pages=f46-f56&amp;pmid=29566126&amp;doi=10.1093/europace/euy042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-biomedicines-11-00334">
<span class="label">30.</span><cite>Buljubasic F., El-Battrawy I., Lan H., Lomada S.K., Chatterjee A., Zhao Z., Li X., Zhong R., Xu Q., Huang M., et al.  Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy. J. Clin. Med. 2020;9:486.  doi: 10.3390/jcm9020486.</cite> [<a href="https://doi.org/10.3390/jcm9020486" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7073527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32050722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Nucleoside%20Diphosphate%20Kinase%20B%20Contributes%20to%20Arrhythmogenesis%20in%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20from%20a%20Patient%20with%20Arrhythmogenic%20Right%20Ventricular%20Cardiomyopathy&amp;author=F.%20Buljubasic&amp;author=I.%20El-Battrawy&amp;author=H.%20Lan&amp;author=S.K.%20Lomada&amp;author=A.%20Chatterjee&amp;volume=9&amp;publication_year=2020&amp;pages=486&amp;pmid=32050722&amp;doi=10.3390/jcm9020486&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-biomedicines-11-00334">
<span class="label">31.</span><cite>Priori S.G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D., Hatala R., Hindricks G., et al.  2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) Eur. Heart J. 2015;36:2793–2867. doi: 10.1093/eurheartj/ehv316.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26320108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=2015%20ESC%20Guidelines%20for%20the%20management%20of%20patients%20with%20ventricular%20arrhythmias%20and%20the%20prevention%20of%20sudden%20cardiac%20death:%20The%20Task%20Force%20for%20the%20Management%20of%20Patients%20with%20Ventricular%20Arrhythmias%20and%20the%20Prevention%20of%20Sudden%20Cardiac%20Death%20of%20the%20European%20Society%20of%20Cardiology%20(ESC).%20Endorsed%20by:%20Association%20for%20European%20Paediatric%20and%20Congenital%20Cardiology%20(AEPC)&amp;author=S.G.%20Priori&amp;author=C.%20Blomstr%C3%B6m-Lundqvist&amp;author=A.%20Mazzanti&amp;author=N.%20Blom&amp;author=M.%20Borggrefe&amp;volume=36&amp;publication_year=2015&amp;pages=2793-2867&amp;pmid=26320108&amp;doi=10.1093/eurheartj/ehv316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-biomedicines-11-00334">
<span class="label">32.</span><cite>Ponce-Balbuena D., Deschênes I. Long QT syndrome–Bench to bedside. Heart Rhythm. O2. 2021;2:89–106. doi: 10.1016/j.hroo.2021.01.006.</cite> [<a href="https://doi.org/10.1016/j.hroo.2021.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8183884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34113909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm.%20O2&amp;title=Long%20QT%20syndrome%E2%80%93Bench%20to%20bedside&amp;author=D.%20Ponce-Balbuena&amp;author=I.%20Desch%C3%AAnes&amp;volume=2&amp;publication_year=2021&amp;pages=89-106&amp;pmid=34113909&amp;doi=10.1016/j.hroo.2021.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-biomedicines-11-00334">
<span class="label">33.</span><cite>Cerrone M., Costa S., Delmar M. The Genetics of Brugada Syndrome. Annu. Rev. Genom. Hum. Genet. 2022;23:255–274. doi: 10.1146/annurev-genom-112921-011200.</cite> [<a href="https://doi.org/10.1146/annurev-genom-112921-011200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35567276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Genom.%20Hum.%20Genet.&amp;title=The%20Genetics%20of%20Brugada%20Syndrome&amp;author=M.%20Cerrone&amp;author=S.%20Costa&amp;author=M.%20Delmar&amp;volume=23&amp;publication_year=2022&amp;pages=255-274&amp;pmid=35567276&amp;doi=10.1146/annurev-genom-112921-011200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-biomedicines-11-00334">
<span class="label">34.</span><cite>Vutthikraivit W., Rattanawong P., Putthapiban P., Sukhumthammarat W., Vathesatogkit P., Ngarmukos T., Thakkinstian A. Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis. Acta Cardiol. Sin. 2018;34:267–277. doi: 10.6515/ACS.201805_34(3).20180302B.</cite> [<a href="https://doi.org/10.6515/ACS.201805_34(3).20180302B" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5968343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29844648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Cardiol.%20Sin.&amp;title=Worldwide%20Prevalence%20of%20Brugada%20Syndrome:%20A%20Systematic%20Review%20and%20Meta-Analysis&amp;author=W.%20Vutthikraivit&amp;author=P.%20Rattanawong&amp;author=P.%20Putthapiban&amp;author=W.%20Sukhumthammarat&amp;author=P.%20Vathesatogkit&amp;volume=34&amp;publication_year=2018&amp;pages=267-277&amp;pmid=29844648&amp;doi=10.6515/ACS.201805_34(3).20180302B&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-biomedicines-11-00334">
<span class="label">35.</span><cite>Nijak A., Saenen J., Labro A., Schepers D., Loeys B., Alaerts M. iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives. Int. J. Mol. Sci. 2021;22:2825.  doi: 10.3390/ijms22062825.</cite> [<a href="https://doi.org/10.3390/ijms22062825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8001521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33802229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=iPSC-Cardiomyocyte%20Models%20of%20Brugada%20Syndrome%E2%80%94Achievements,%20Challenges%20and%20Future%20Perspectives&amp;author=A.%20Nijak&amp;author=J.%20Saenen&amp;author=A.%20Labro&amp;author=D.%20Schepers&amp;author=B.%20Loeys&amp;volume=22&amp;publication_year=2021&amp;pages=2825&amp;pmid=33802229&amp;doi=10.3390/ijms22062825&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-biomedicines-11-00334">
<span class="label">36.</span><cite>Campuzano O., Sarquella-Brugada G., Cesar S., Arbelo E., Brugada J., Brugada R. Recent Advances in Short QT Syndrome. Front. Cardiovasc. Med. 2018;5:149. doi: 10.3389/fcvm.2018.00149.</cite> [<a href="https://doi.org/10.3389/fcvm.2018.00149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6215807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30420954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cardiovasc.%20Med.&amp;title=Recent%20Advances%20in%20Short%20QT%20Syndrome&amp;author=O.%20Campuzano&amp;author=G.%20Sarquella-Brugada&amp;author=S.%20Cesar&amp;author=E.%20Arbelo&amp;author=J.%20Brugada&amp;volume=5&amp;publication_year=2018&amp;pages=149&amp;pmid=30420954&amp;doi=10.3389/fcvm.2018.00149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-biomedicines-11-00334">
<span class="label">37.</span><cite>Walsh R., Adler A., Amin A.S., Abiusi E., Care M., Bikker H., Amenta S., Feilotter H., Nannenberg E.A., Mazzarotto F., et al.  Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur. Heart J. 2022;43:1500–1510. doi: 10.1093/eurheartj/ehab687.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehab687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9009401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34557911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Evaluation%20of%20gene%20validity%20for%20CPVT%20and%20short%20QT%20syndrome%20in%20sudden%20arrhythmic%20death&amp;author=R.%20Walsh&amp;author=A.%20Adler&amp;author=A.S.%20Amin&amp;author=E.%20Abiusi&amp;author=M.%20Care&amp;volume=43&amp;publication_year=2022&amp;pages=1500-1510&amp;pmid=34557911&amp;doi=10.1093/eurheartj/ehab687&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-biomedicines-11-00334">
<span class="label">38.</span><cite>Leenhardt A., Denjoy I., Guicheney P. Catecholaminergic Polymorphic Ventricular Tachycardia. Circ. Arrhythmia Electrophysiol. 2012;5:1044–1052. doi: 10.1161/CIRCEP.111.962027.</cite> [<a href="https://doi.org/10.1161/CIRCEP.111.962027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23022705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Arrhythmia%20Electrophysiol.&amp;title=Catecholaminergic%20Polymorphic%20Ventricular%20Tachycardia&amp;author=A.%20Leenhardt&amp;author=I.%20Denjoy&amp;author=P.%20Guicheney&amp;volume=5&amp;publication_year=2012&amp;pages=1044-1052&amp;pmid=23022705&amp;doi=10.1161/CIRCEP.111.962027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-biomedicines-11-00334">
<span class="label">39.</span><cite>Corrado D., Basso C., Judge D.P. Arrhythmogenic Cardiomyopathy. Circ. Res. 2017;121:784–802. doi: 10.1161/CIRCRESAHA.117.309345.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.117.309345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28912183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Arrhythmogenic%20Cardiomyopathy&amp;author=D.%20Corrado&amp;author=C.%20Basso&amp;author=D.P.%20Judge&amp;volume=121&amp;publication_year=2017&amp;pages=784-802&amp;pmid=28912183&amp;doi=10.1161/CIRCRESAHA.117.309345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-biomedicines-11-00334">
<span class="label">40.</span><cite>Ahmed R.E., Anzai T., Chanthra N., Uosaki H. A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes. Front. Cell Dev. Biol. 2020;8:178. doi: 10.3389/fcell.2020.00178.</cite> [<a href="https://doi.org/10.3389/fcell.2020.00178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7096382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32266260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell%20Dev.%20Biol.&amp;title=A%20Brief%20Review%20of%20Current%20Maturation%20Methods%20for%20Human%20Induced%20Pluripotent%20Stem%20Cells-Derived%20Cardiomyocytes&amp;author=R.E.%20Ahmed&amp;author=T.%20Anzai&amp;author=N.%20Chanthra&amp;author=H.%20Uosaki&amp;volume=8&amp;publication_year=2020&amp;pages=178&amp;pmid=32266260&amp;doi=10.3389/fcell.2020.00178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-biomedicines-11-00334">
<span class="label">41.</span><cite>Litviňuková M., Talavera-López C., Maatz H., Reichart D., Worth C.L., Lindberg E.L., Kanda M., Polanski K., Heinig M., Lee M., et al.  Cells of the adult human heart. Nature. 2020;588:466–472. doi: 10.1038/s41586-020-2797-4.</cite> [<a href="https://doi.org/10.1038/s41586-020-2797-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7681775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32971526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cells%20of%20the%20adult%20human%20heart&amp;author=M.%20Litvi%C5%88ukov%C3%A1&amp;author=C.%20Talavera-L%C3%B3pez&amp;author=H.%20Maatz&amp;author=D.%20Reichart&amp;author=C.L.%20Worth&amp;volume=588&amp;publication_year=2020&amp;pages=466-472&amp;pmid=32971526&amp;doi=10.1038/s41586-020-2797-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-biomedicines-11-00334">
<span class="label">42.</span><cite>Pinto A.R., Ilinykh A., Ivey M.J., Kuwabara J.T., D’Antoni M.L., Debuque R., Chandran A., Wang L., Arora K., Rosenthal N., et al.  Revisiting Cardiac Cellular Composition. Circ. Res. 2016;118:400–409. doi: 10.1161/CIRCRESAHA.115.307778.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.115.307778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4744092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26635390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Revisiting%20Cardiac%20Cellular%20Composition&amp;author=A.R.%20Pinto&amp;author=A.%20Ilinykh&amp;author=M.J.%20Ivey&amp;author=J.T.%20Kuwabara&amp;author=M.L.%20D%E2%80%99Antoni&amp;volume=118&amp;publication_year=2016&amp;pages=400-409&amp;pmid=26635390&amp;doi=10.1161/CIRCRESAHA.115.307778&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-biomedicines-11-00334">
<span class="label">43.</span><cite>Bai Y., Yeung E., Lui C., Ong C.S., Pitaktong I., Huang C., Inoue T., Matsushita H., Ma C., Hibino N. A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation. J. Vis. Exp. 2018:e58252. doi: 10.3791/58252.</cite> [<a href="https://doi.org/10.3791/58252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6126624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30124650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Vis.%20Exp.&amp;title=A%20Net%20Mold-based%20Method%20of%20Scaffold-free%20Three-Dimensional%20Cardiac%20Tissue%20Creation&amp;author=Y.%20Bai&amp;author=E.%20Yeung&amp;author=C.%20Lui&amp;author=C.S.%20Ong&amp;author=I.%20Pitaktong&amp;publication_year=2018&amp;pages=e58252&amp;pmid=30124650&amp;doi=10.3791/58252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-biomedicines-11-00334">
<span class="label">44.</span><cite>Sharma P., Gentile C. Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology. J. Vis. Exp. 2021:e61962. doi: 10.3791/61962.</cite> [<a href="https://doi.org/10.3791/61962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33554972/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Vis.%20Exp.&amp;title=Cardiac%20Spheroids%20as%20in%20vitro%20Bioengineered%20Heart%20Tissues%20to%20Study%20Human%20Heart%20Pathophysiology&amp;author=P.%20Sharma&amp;author=C.%20Gentile&amp;publication_year=2021&amp;pages=e61962&amp;pmid=33554972&amp;doi=10.3791/61962&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-biomedicines-11-00334">
<span class="label">45.</span><cite>Beauchamp P., Moritz W., Kelm J.M., Ullrich N., Agarkova I., Anson B.D., Suter T.M., Zuppinger C. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes. Tissue Eng. Part C Methods. 2015;21:852–861. doi: 10.1089/ten.tec.2014.0376.</cite> [<a href="https://doi.org/10.1089/ten.tec.2014.0376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25654582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tissue%20Eng.%20Part%20C%20Methods&amp;title=Development%20and%20Characterization%20of%20a%20Scaffold-Free%203D%20Spheroid%20Model%20of%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Human%20Cardiomyocytes&amp;author=P.%20Beauchamp&amp;author=W.%20Moritz&amp;author=J.M.%20Kelm&amp;author=N.%20Ullrich&amp;author=I.%20Agarkova&amp;volume=21&amp;publication_year=2015&amp;pages=852-861&amp;pmid=25654582&amp;doi=10.1089/ten.tec.2014.0376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-biomedicines-11-00334">
<span class="label">46.</span><cite>Ergir E., La Cruz J.O.-D., Fernandes S., Cassani M., Niro F., Pereira-Sousa D., Vrbský J., Vinarský V., Perestrelo A.R., Debellis D., et al.  Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. Sci. Rep. 2022;12:17409. doi: 10.1038/s41598-022-22225-w.</cite> [<a href="https://doi.org/10.1038/s41598-022-22225-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9579206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36257968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Generation%20and%20maturation%20of%20human%20iPSC-derived%203D%20organotypic%20cardiac%20microtissues%20in%20long-term%20culture&amp;author=E.%20Ergir&amp;author=J.O.-D.%20La%20Cruz&amp;author=S.%20Fernandes&amp;author=M.%20Cassani&amp;author=F.%20Niro&amp;volume=12&amp;publication_year=2022&amp;pages=17409&amp;pmid=36257968&amp;doi=10.1038/s41598-022-22225-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-biomedicines-11-00334">
<span class="label">47.</span><cite>Drakhlis L., Biswanath S., Farr C.-M., Lupanow V., Teske J., Ritzenhoff K., Franke A., Manstein F., Bolesani E., Kempf H., et al.  Human heart-forming organoids recapitulate early heart and foregut development. Nat. Biotechnol. 2021;39:737–746. doi: 10.1038/s41587-021-00815-9.</cite> [<a href="https://doi.org/10.1038/s41587-021-00815-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8192303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33558697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Human%20heart-forming%20organoids%20recapitulate%20early%20heart%20and%20foregut%20development&amp;author=L.%20Drakhlis&amp;author=S.%20Biswanath&amp;author=C.-M.%20Farr&amp;author=V.%20Lupanow&amp;author=J.%20Teske&amp;volume=39&amp;publication_year=2021&amp;pages=737-746&amp;pmid=33558697&amp;doi=10.1038/s41587-021-00815-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-biomedicines-11-00334">
<span class="label">48.</span><cite>Lewis-Israeli Y.R., Wasserman A.H., Gabalski M.A., Volmert B.D., Ming Y., Ball K.A., Yang W., Zou J., Ni G., Pajares N., et al.  Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat. Commun. 2021;12:5142. doi: 10.1038/s41467-021-25329-5.</cite> [<a href="https://doi.org/10.1038/s41467-021-25329-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8390749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34446706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Self-assembling%20human%20heart%20organoids%20for%20the%20modeling%20of%20cardiac%20development%20and%20congenital%20heart%20disease&amp;author=Y.R.%20Lewis-Israeli&amp;author=A.H.%20Wasserman&amp;author=M.A.%20Gabalski&amp;author=B.D.%20Volmert&amp;author=Y.%20Ming&amp;volume=12&amp;publication_year=2021&amp;pages=5142&amp;pmid=34446706&amp;doi=10.1038/s41467-021-25329-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-biomedicines-11-00334">
<span class="label">49.</span><cite>Lee S.-G., Kim Y.-J., Son M.-Y., Oh M.-S., Kim J., Ryu B., Kang K.-R., Baek J., Chung G., Woo D.H., et al.  Generation of human iPSCs derived heart organoids structurally and functionally similar to heart. Biomaterials. 2022;290:121860. doi: 10.1016/j.biomaterials.2022.121860.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2022.121860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36274511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Generation%20of%20human%20iPSCs%20derived%20heart%20organoids%20structurally%20and%20functionally%20similar%20to%20heart&amp;author=S.-G.%20Lee&amp;author=Y.-J.%20Kim&amp;author=M.-Y.%20Son&amp;author=M.-S.%20Oh&amp;author=J.%20Kim&amp;volume=290&amp;publication_year=2022&amp;pages=121860&amp;pmid=36274511&amp;doi=10.1016/j.biomaterials.2022.121860&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-biomedicines-11-00334">
<span class="label">50.</span><cite>Giacomelli E., Meraviglia V., Campostrini G., Cochrane A., Cao X., van Helden R.W., Garcia A.K., Mircea M., Kostidis S., Davis R.P., et al.  Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020;26:862–879. doi: 10.1016/j.stem.2020.05.004.</cite> [<a href="https://doi.org/10.1016/j.stem.2020.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7284308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32459996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Human-iPSC-Derived%20Cardiac%20Stromal%20Cells%20Enhance%20Maturation%20in%203D%20Cardiac%20Microtissues%20and%20Reveal%20Non-cardiomyocyte%20Contributions%20to%20Heart%20Disease&amp;author=E.%20Giacomelli&amp;author=V.%20Meraviglia&amp;author=G.%20Campostrini&amp;author=A.%20Cochrane&amp;author=X.%20Cao&amp;volume=26&amp;publication_year=2020&amp;pages=862-879&amp;pmid=32459996&amp;doi=10.1016/j.stem.2020.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-biomedicines-11-00334">
<span class="label">51.</span><cite>Prajapati C., Ojala M., Lappi H., Aalto-Setälä K., Pekkanen-Mattila M. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods. Stem Cell Res. 2021;51:102176. doi: 10.1016/j.scr.2021.102176.</cite> [<a href="https://doi.org/10.1016/j.scr.2021.102176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33485184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Res.&amp;title=Electrophysiological%20evaluation%20of%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20obtained%20by%20different%20methods&amp;author=C.%20Prajapati&amp;author=M.%20Ojala&amp;author=H.%20Lappi&amp;author=K.%20Aalto-Set%C3%A4l%C3%A4&amp;author=M.%20Pekkanen-Mattila&amp;volume=51&amp;publication_year=2021&amp;pages=102176&amp;pmid=33485184&amp;doi=10.1016/j.scr.2021.102176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-biomedicines-11-00334">
<span class="label">52.</span><cite>Giacomelli E., Sala L., Oostwaard D.W.-V., Bellin M. Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome. Biochem. Biophys. Res. Commun. 2021;572:118–124. doi: 10.1016/j.bbrc.2021.07.068.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2021.07.068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34364290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Cardiac%20microtissues%20from%20human%20pluripotent%20stem%20cells%20recapitulate%20the%20phenotype%20of%20long-QT%20syndrome&amp;author=E.%20Giacomelli&amp;author=L.%20Sala&amp;author=D.W.-V.%20Oostwaard&amp;author=M.%20Bellin&amp;volume=572&amp;publication_year=2021&amp;pages=118-124&amp;pmid=34364290&amp;doi=10.1016/j.bbrc.2021.07.068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-biomedicines-11-00334">
<span class="label">53.</span><cite>Goldfracht I., Efraim Y., Shinnawi R., Kovalev E., Huber I., Gepstein A., Arbel G., Shaheen N., Tiburcy M., Zimmermann W.H., et al.  Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Acta Biomater. 2019;92:145–159. doi: 10.1016/j.actbio.2019.05.016.</cite> [<a href="https://doi.org/10.1016/j.actbio.2019.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31075518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biomater.&amp;title=Engineered%20heart%20tissue%20models%20from%20hiPSC-derived%20cardiomyocytes%20and%20cardiac%20ECM%20for%20disease%20modeling%20and%20drug%20testing%20applications&amp;author=I.%20Goldfracht&amp;author=Y.%20Efraim&amp;author=R.%20Shinnawi&amp;author=E.%20Kovalev&amp;author=I.%20Huber&amp;volume=92&amp;publication_year=2019&amp;pages=145-159&amp;pmid=31075518&amp;doi=10.1016/j.actbio.2019.05.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-biomedicines-11-00334">
<span class="label">54.</span><cite>Fong A.H., Romero-López M., Heylman C.M., Keating M., Tran D., Sobrino A., Tran A.Q., Pham H.H., Fimbres C., Gershon P.D., et al.  Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Tissue Eng. Part A. 2016;22:1016–1025. doi: 10.1089/ten.tea.2016.0027.</cite> [<a href="https://doi.org/10.1089/ten.tea.2016.0027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4991595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27392582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tissue%20Eng.%20Part%20A&amp;title=Three-Dimensional%20Adult%20Cardiac%20Extracellular%20Matrix%20Promotes%20Maturation%20of%20Human%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=A.H.%20Fong&amp;author=M.%20Romero-L%C3%B3pez&amp;author=C.M.%20Heylman&amp;author=M.%20Keating&amp;author=D.%20Tran&amp;volume=22&amp;publication_year=2016&amp;pages=1016-1025&amp;pmid=27392582&amp;doi=10.1089/ten.tea.2016.0027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-biomedicines-11-00334">
<span class="label">55.</span><cite>Zhang M., Xu Y., Chen Y., Yan Q., Li X., Ding L., Wei T., Zeng D. Three-Dimensional Poly-(ε-Caprolactone) Nanofibrous Scaffolds Promote the Maturation of Human Pluripotent Stem Cells-Induced Cardiomyocytes. Front. Cell Dev. Biol. 2022;10:875278. doi: 10.3389/fcell.2022.875278.</cite> [<a href="https://doi.org/10.3389/fcell.2022.875278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9377449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35979378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell%20Dev.%20Biol.&amp;title=Three-Dimensional%20Poly-(%CE%B5-Caprolactone)%20Nanofibrous%20Scaffolds%20Promote%20the%20Maturation%20of%20Human%20Pluripotent%20Stem%20Cells-Induced%20Cardiomyocytes&amp;author=M.%20Zhang&amp;author=Y.%20Xu&amp;author=Y.%20Chen&amp;author=Q.%20Yan&amp;author=X.%20Li&amp;volume=10&amp;publication_year=2022&amp;pages=875278&amp;pmid=35979378&amp;doi=10.3389/fcell.2022.875278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-biomedicines-11-00334">
<span class="label">56.</span><cite>Chen Y., Chan J.P.Y., Wu J., Li R., Santerre J.P. Compatibility and function of human induced pluripotent stem cell derived cardiomyocytes on an electrospun nanofibrous scaffold, generated from an ionomeric polyurethane composite. J. Biomed. Mater. Res. Part A. 2022;110:1932–1943. doi: 10.1002/jbm.a.37428.</cite> [<a href="https://doi.org/10.1002/jbm.a.37428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35851742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomed.%20Mater.%20Res.%20Part%20A&amp;title=Compatibility%20and%20function%20of%20human%20induced%20pluripotent%20stem%20cell%20derived%20cardiomyocytes%20on%20an%20electrospun%20nanofibrous%20scaffold,%20generated%20from%20an%20ionomeric%20polyurethane%20composite&amp;author=Y.%20Chen&amp;author=J.P.Y.%20Chan&amp;author=J.%20Wu&amp;author=R.%20Li&amp;author=J.P.%20Santerre&amp;volume=110&amp;publication_year=2022&amp;pages=1932-1943&amp;pmid=35851742&amp;doi=10.1002/jbm.a.37428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57-biomedicines-11-00334">
<span class="label">57.</span><cite>Sacchetto C., Vitiello L., De Windt L.J., Rampazzo A., Calore M. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures. Int. J. Mol. Sci. 2020;21:3404.  doi: 10.3390/ijms21093404.</cite> [<a href="https://doi.org/10.3390/ijms21093404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7246991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32403456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Modeling%20Cardiovascular%20Diseases%20with%20hiPSC-Derived%20Cardiomyocytes%20in%202D%20and%203D%20Cultures&amp;author=C.%20Sacchetto&amp;author=L.%20Vitiello&amp;author=L.J.%20De%20Windt&amp;author=A.%20Rampazzo&amp;author=M.%20Calore&amp;volume=21&amp;publication_year=2020&amp;pages=3404&amp;pmid=32403456&amp;doi=10.3390/ijms21093404&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58-biomedicines-11-00334">
<span class="label">58.</span><cite>Lemoine M.D., Mannhardt I., Breckwoldt K., Prondzynski M., Flenner F., Ulmer B., Hirt M.N., Neuber C., Horváth A., Kloth B., et al.  Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci. Rep. 2017;7:5464. doi: 10.1038/s41598-017-05600-w.</cite> [<a href="https://doi.org/10.1038/s41598-017-05600-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5511281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28710467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Human%20iPSC-derived%20cardiomyocytes%20cultured%20in%203D%20engineered%20heart%20tissue%20show%20physiological%20upstroke%20velocity%20and%20sodium%20current%20density&amp;author=M.D.%20Lemoine&amp;author=I.%20Mannhardt&amp;author=K.%20Breckwoldt&amp;author=M.%20Prondzynski&amp;author=F.%20Flenner&amp;volume=7&amp;publication_year=2017&amp;pages=5464&amp;pmid=28710467&amp;doi=10.1038/s41598-017-05600-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59-biomedicines-11-00334">
<span class="label">59.</span><cite>Ronaldson-Bouchard K., Ma S.P., Yeager K., Chen T., Song L., Sirabella D., Morikawa K., Teles D., Yazawa M., Vunjak-Novakovic G. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018;556:239–243. doi: 10.1038/s41586-018-0016-3.</cite> [<a href="https://doi.org/10.1038/s41586-018-0016-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5895513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29618819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Advanced%20maturation%20of%20human%20cardiac%20tissue%20grown%20from%20pluripotent%20stem%20cells&amp;author=K.%20Ronaldson-Bouchard&amp;author=S.P.%20Ma&amp;author=K.%20Yeager&amp;author=T.%20Chen&amp;author=L.%20Song&amp;volume=556&amp;publication_year=2018&amp;pages=239-243&amp;pmid=29618819&amp;doi=10.1038/s41586-018-0016-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60-biomedicines-11-00334">
<span class="label">60.</span><cite>Lu K., Seidel T., Cao-Ehlker X., Dorn T., Batcha A.M.N., Schneider C.M., Semmler M., Volk T., Moretti A., Dendorfer A., et al.  Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium. Theranostics. 2021;11:6138–6153. doi: 10.7150/thno.54999.</cite> [<a href="https://doi.org/10.7150/thno.54999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8120210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33995650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Progressive%20stretch%20enhances%20growth%20and%20maturation%20of%203D%20stem-cell-derived%20myocardium&amp;author=K.%20Lu&amp;author=T.%20Seidel&amp;author=X.%20Cao-Ehlker&amp;author=T.%20Dorn&amp;author=A.M.N.%20Batcha&amp;volume=11&amp;publication_year=2021&amp;pages=6138-6153&amp;pmid=33995650&amp;doi=10.7150/thno.54999&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61-biomedicines-11-00334">
<span class="label">61.</span><cite>Yang Q., Xiao Z., Lv X., Zhang T., Liu H. Fabrication and Biomedical Applications of Heart-on-a-chip. Int. J. Bioprint. 2021;7:370. doi: 10.18063/ijb.v7i3.370.</cite> [<a href="https://doi.org/10.18063/ijb.v7i3.370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8287510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34286153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Bioprint&amp;title=Fabrication%20and%20Biomedical%20Applications%20of%20Heart-on-a-chip&amp;author=Q.%20Yang&amp;author=Z.%20Xiao&amp;author=X.%20Lv&amp;author=T.%20Zhang&amp;author=H.%20Liu&amp;volume=7&amp;publication_year=2021&amp;pages=370&amp;pmid=34286153&amp;doi=10.18063/ijb.v7i3.370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62-biomedicines-11-00334">
<span class="label">62.</span><cite>Varzideh F., Mone P., Santulli G. Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells. Bioengineering. 2022;9:168.  doi: 10.3390/bioengineering9040168.</cite> [<a href="https://doi.org/10.3390/bioengineering9040168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9028595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35447728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioengineering&amp;title=Bioengineering%20Strategies%20to%20Create%203D%20Cardiac%20Constructs%20from%20Human%20Induced%20Pluripotent%20Stem%20Cells&amp;author=F.%20Varzideh&amp;author=P.%20Mone&amp;author=G.%20Santulli&amp;volume=9&amp;publication_year=2022&amp;pages=168&amp;pmid=35447728&amp;doi=10.3390/bioengineering9040168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63-biomedicines-11-00334">
<span class="label">63.</span><cite>Paloschi V., Sabater-Lleal M., Middelkamp H., Vivas A., Johansson S., van der Meer A., Tenje M., Maegdefessel L. Organ-on-a-chip technology: A novel approach to investigate cardiovascular diseases. Cardiovasc. Res. 2021;117:2742–2754. doi: 10.1093/cvr/cvab088.</cite> [<a href="https://doi.org/10.1093/cvr/cvab088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8683705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33729461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Organ-on-a-chip%20technology:%20A%20novel%20approach%20to%20investigate%20cardiovascular%20diseases&amp;author=V.%20Paloschi&amp;author=M.%20Sabater-Lleal&amp;author=H.%20Middelkamp&amp;author=A.%20Vivas&amp;author=S.%20Johansson&amp;volume=117&amp;publication_year=2021&amp;pages=2742-2754&amp;pmid=33729461&amp;doi=10.1093/cvr/cvab088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64-biomedicines-11-00334">
<span class="label">64.</span><cite>Liu H., Bolonduro O.A., Hu N., Ju J., Rao A.A., Duffy B.M., Huang Z., Black L.D., Timko B.P. Heart-on-a-Chip Model with Integrated Extra- and Intracellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia. Nano Lett. 2020;20:2585–2593. doi: 10.1021/acs.nanolett.0c00076.</cite> [<a href="https://doi.org/10.1021/acs.nanolett.0c00076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32092276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett.&amp;title=Heart-on-a-Chip%20Model%20with%20Integrated%20Extra-%20and%20Intracellular%20Bioelectronics%20for%20Monitoring%20Cardiac%20Electrophysiology%20under%20Acute%20Hypoxia&amp;author=H.%20Liu&amp;author=O.A.%20Bolonduro&amp;author=N.%20Hu&amp;author=J.%20Ju&amp;author=A.A.%20Rao&amp;volume=20&amp;publication_year=2020&amp;pages=2585-2593&amp;pmid=32092276&amp;doi=10.1021/acs.nanolett.0c00076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65-biomedicines-11-00334">
<span class="label">65.</span><cite>Conant G., Lai B.F.L., Lu R.X.Z., Korolj A., Wang E.Y., Radisic M. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model. Stem Cell Rev. Rep. 2017;13:335–346. doi: 10.1007/s12015-017-9736-2.</cite> [<a href="https://doi.org/10.1007/s12015-017-9736-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28429185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Rev.%20Rep.&amp;title=High-Content%20Assessment%20of%20Cardiac%20Function%20Using%20Heart-on-a-Chip%20Devices%20as%20Drug%20Screening%20Model&amp;author=G.%20Conant&amp;author=B.F.L.%20Lai&amp;author=R.X.Z.%20Lu&amp;author=A.%20Korolj&amp;author=E.Y.%20Wang&amp;volume=13&amp;publication_year=2017&amp;pages=335-346&amp;pmid=28429185&amp;doi=10.1007/s12015-017-9736-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66-biomedicines-11-00334">
<span class="label">66.</span><cite>Zhao Y., Rafatian N., Wang E.Y., Wu Q., Lai B.F., Lu R.X., Savoji H., Radisic M. Towards chamber specific heart-on-a-chip for drug testing applications. Adv. Drug Deliv. Rev. 2020;165–166:60–76. doi: 10.1016/j.addr.2019.12.002.</cite> [<a href="https://doi.org/10.1016/j.addr.2019.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7338250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31917972/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Drug%20Deliv.%20Rev.&amp;title=Towards%20chamber%20specific%20heart-on-a-chip%20for%20drug%20testing%20applications&amp;author=Y.%20Zhao&amp;author=N.%20Rafatian&amp;author=E.Y.%20Wang&amp;author=Q.%20Wu&amp;author=B.F.%20Lai&amp;volume=165%E2%80%93166&amp;publication_year=2020&amp;pages=60-76&amp;pmid=31917972&amp;doi=10.1016/j.addr.2019.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67-biomedicines-11-00334">
<span class="label">67.</span><cite>Colatsky T., Fermini B., Gintant G., Pierson J.B., Sager P., Sekino Y., Strauss D.G., Stockbridge N. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. J. Pharmacol. Toxicol. Methods. 2016;81:15–20. doi: 10.1016/j.vascn.2016.06.002.</cite> [<a href="https://doi.org/10.1016/j.vascn.2016.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27282641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Toxicol.%20Methods&amp;title=The%20Comprehensive%20in%20Vitro%20Proarrhythmia%20Assay%20(CiPA)%20initiative%E2%80%94Update%20on%20progress&amp;author=T.%20Colatsky&amp;author=B.%20Fermini&amp;author=G.%20Gintant&amp;author=J.B.%20Pierson&amp;author=P.%20Sager&amp;volume=81&amp;publication_year=2016&amp;pages=15-20&amp;pmid=27282641&amp;doi=10.1016/j.vascn.2016.06.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68-biomedicines-11-00334">
<span class="label">68.</span><cite>Blinova K., Stohlman J., Vicente J., Chan D., Johannesen L., Hortigon-Vinagre M.P., Zamora V., Smith G., Crumb W.J., Pang L., et al.  Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias. Toxicol. Sci. 2017;155:234–247. doi: 10.1093/toxsci/kfw200.</cite> [<a href="https://doi.org/10.1093/toxsci/kfw200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6093617/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27701120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20Sci.&amp;title=Comprehensive%20Translational%20Assessment%20of%20Human-Induced%20Pluripotent%20Stem%20Cell%20Derived%20Cardiomyocytes%20for%20Evaluating%20Drug-Induced%20Arrhythmias&amp;author=K.%20Blinova&amp;author=J.%20Stohlman&amp;author=J.%20Vicente&amp;author=D.%20Chan&amp;author=L.%20Johannesen&amp;volume=155&amp;publication_year=2017&amp;pages=234-247&amp;pmid=27701120&amp;doi=10.1093/toxsci/kfw200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69-biomedicines-11-00334">
<span class="label">69.</span><cite>Millard D., Dang Q., Shi H., Zhang X., Strock C., Kraushaar U., Zeng H., Levesque P., Lu H.-R., Guillon J.-M., et al.  Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study. Toxicol. Sci. 2018;164:550–562. doi: 10.1093/toxsci/kfy110.</cite> [<a href="https://doi.org/10.1093/toxsci/kfy110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6061700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29718449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20Sci.&amp;title=Cross-Site%20Reliability%20of%20Human%20Induced%20Pluripotent%20stem%20cell-derived%20Cardiomyocyte%20Based%20Safety%20Assays%20Using%20Microelectrode%20Arrays:%20Results%20from%20a%20Blinded%20CiPA%20Pilot%20Study&amp;author=D.%20Millard&amp;author=Q.%20Dang&amp;author=H.%20Shi&amp;author=X.%20Zhang&amp;author=C.%20Strock&amp;volume=164&amp;publication_year=2018&amp;pages=550-562&amp;pmid=29718449&amp;doi=10.1093/toxsci/kfy110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70-biomedicines-11-00334">
<span class="label">70.</span><cite>Kitaguchi T., Moriyama Y., Taniguchi T., Ojima A., Ando H., Uda T., Otabe K., Oguchi M., Shimizu S., Saito H., et al.  CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia—Effects of 7 reference compounds at 10 facilities. J. Pharmacol. Toxicol. Methods. 2016;78:93–102. doi: 10.1016/j.vascn.2015.12.002.</cite> [<a href="https://doi.org/10.1016/j.vascn.2015.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26657830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharmacol.%20Toxicol.%20Methods&amp;title=CSAHi%20study:%20Evaluation%20of%20multi-electrode%20array%20in%20combination%20with%20human%20iPS%20cell-derived%20cardiomyocytes%20to%20predict%20drug-induced%20QT%20prolongation%20and%20arrhythmia%E2%80%94Effects%20of%207%20reference%20compounds%20at%2010%20facilities&amp;author=T.%20Kitaguchi&amp;author=Y.%20Moriyama&amp;author=T.%20Taniguchi&amp;author=A.%20Ojima&amp;author=H.%20Ando&amp;volume=78&amp;publication_year=2016&amp;pages=93-102&amp;pmid=26657830&amp;doi=10.1016/j.vascn.2015.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71-biomedicines-11-00334">
<span class="label">71.</span><cite>Yamamoto W., Asakura K., Ando H., Taniguchi T., Ojima A., Uda T., Osada T., Hayashi S., Kasai C., Miyamoto N., et al.  Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential. PLoS ONE. 2016;11:e0167348.  doi: 10.1371/journal.pone.0167348.</cite> [<a href="https://doi.org/10.1371/journal.pone.0167348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5140066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27923051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Electrophysiological%20Characteristics%20of%20Human%20iPSC-Derived%20Cardiomyocytes%20for%20the%20Assessment%20of%20Drug-Induced%20Proarrhythmic%20Potential&amp;author=W.%20Yamamoto&amp;author=K.%20Asakura&amp;author=H.%20Ando&amp;author=T.%20Taniguchi&amp;author=A.%20Ojima&amp;volume=11&amp;publication_year=2016&amp;pages=e0167348&amp;pmid=27923051&amp;doi=10.1371/journal.pone.0167348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72-biomedicines-11-00334">
<span class="label">72.</span><cite>Lee S.-G., Kim J., Oh M.-S., Ryu B., Kang K.-R., Baek J., Lee J.-M., Choi S.-O., Kim C.-Y., Chung H.M. Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform. Biochem. Biophys. Res. Commun. 2021;555:67–73. doi: 10.1016/j.bbrc.2021.03.039.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2021.03.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33813278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Development%20and%20validation%20of%20dual-cardiotoxicity%20evaluation%20method%20based%20on%20analysis%20of%20field%20potential%20and%20contractile%20force%20of%20human%20iPSC-derived%20cardiomyocytes%20/%20multielectrode%20assay%20platform&amp;author=S.-G.%20Lee&amp;author=J.%20Kim&amp;author=M.-S.%20Oh&amp;author=B.%20Ryu&amp;author=K.-R.%20Kang&amp;volume=555&amp;publication_year=2021&amp;pages=67-73&amp;pmid=33813278&amp;doi=10.1016/j.bbrc.2021.03.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73-biomedicines-11-00334">
<span class="label">73.</span><cite>Visone R., Lozano-Juan F., Marzorati S., Rivolta M.W., Pesenti E., Redaelli A., Sassi R., Rasponi M., Occhetta P. Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform. Toxicol. Sci. 2022;191:47–60. doi: 10.1093/toxsci/kfac108.</cite> [<a href="https://doi.org/10.1093/toxsci/kfac108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9887672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36226800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20Sci.&amp;title=Predicting%20human%20cardiac%20QT%20alterations%20and%20pro-arrhythmic%20effects%20of%20compounds%20with%20a%203D%20beating%20heart-on-chip%20platform&amp;author=R.%20Visone&amp;author=F.%20Lozano-Juan&amp;author=S.%20Marzorati&amp;author=M.W.%20Rivolta&amp;author=E.%20Pesenti&amp;volume=191&amp;publication_year=2022&amp;pages=47-60&amp;pmid=36226800&amp;doi=10.1093/toxsci/kfac108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74-biomedicines-11-00334">
<span class="label">74.</span><cite>Charwat V., Charrez B., Siemons B.A., Finsberg H., Jæger K.H., Edwards A.G., Huebsch N., Wall S., Miller E., Tveito A., et al.  Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System. ACS Pharmacol. Transl. Sci. 2022;5:652–667. doi: 10.1021/acsptsci.2c00088.</cite> [<a href="https://doi.org/10.1021/acsptsci.2c00088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9380217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35983280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Pharmacol.%20Transl.%20Sci.&amp;title=Validating%20the%20Arrhythmogenic%20Potential%20of%20High-,%20Intermediate-,%20and%20Low-Risk%20Drugs%20in%20a%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiac%20Microphysiological%20System&amp;author=V.%20Charwat&amp;author=B.%20Charrez&amp;author=B.A.%20Siemons&amp;author=H.%20Finsberg&amp;author=K.H.%20J%C3%A6ger&amp;volume=5&amp;publication_year=2022&amp;pages=652-667&amp;pmid=35983280&amp;doi=10.1021/acsptsci.2c00088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75-biomedicines-11-00334">
<span class="label">75.</span><cite>McKeithan W.L., Savchenko A., Yu M.S., Cerignoli F., Bruyneel A.A.N., Price J.H., Colas A.R., Miller E.W., Cashman J.R., Mercola M. An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes. Front. Physiol. 2017;8:766. doi: 10.3389/fphys.2017.00766.</cite> [<a href="https://doi.org/10.3389/fphys.2017.00766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5641590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29075196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Physiol.&amp;title=An%20Automated%20Platform%20for%20Assessment%20of%20Congenital%20and%20Drug-Induced%20Arrhythmia%20with%20hiPSC-Derived%20Cardiomyocytes&amp;author=W.L.%20McKeithan&amp;author=A.%20Savchenko&amp;author=M.S.%20Yu&amp;author=F.%20Cerignoli&amp;author=A.A.N.%20Bruyneel&amp;volume=8&amp;publication_year=2017&amp;pages=766&amp;pmid=29075196&amp;doi=10.3389/fphys.2017.00766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76-biomedicines-11-00334">
<span class="label">76.</span><cite>McKeithan W.L., Feyen D.A., Bruyneel A.A., Okolotowicz K.J., Ryan D.A., Sampson K.J., Potet F., Savchenko A., Gómez-Galeno J., Vu M., et al.  Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. Cell Stem Cell. 2020;27:813–821.e6. doi: 10.1016/j.stem.2020.08.003.</cite> [<a href="https://doi.org/10.1016/j.stem.2020.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7655512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32931730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Stem%20Cell&amp;title=Reengineering%20an%20Antiarrhythmic%20Drug%20Using%20Patient%20hiPSC%20Cardiomyocytes%20to%20Improve%20Therapeutic%20Potential%20and%20Reduce%20Toxicity&amp;author=W.L.%20McKeithan&amp;author=D.A.%20Feyen&amp;author=A.A.%20Bruyneel&amp;author=K.J.%20Okolotowicz&amp;author=D.A.%20Ryan&amp;volume=27&amp;publication_year=2020&amp;pages=813-821.e6&amp;pmid=32931730&amp;doi=10.1016/j.stem.2020.08.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77-biomedicines-11-00334">
<span class="label">77.</span><cite>Johnson M., Gomez-Galeno J., Ryan D., Okolotowicz K., McKeithan W.L., Sampson K.J., Kass R.S., Mercola M., Cashman J.R. Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs. Bioorg. Med. Chem. Lett. 2021;46:128162. doi: 10.1016/j.bmcl.2021.128162.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2021.128162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34062251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Human%20iPSC-derived%20cardiomyocytes%20and%20pyridyl-phenyl%20mexiletine%20analogs&amp;author=M.%20Johnson&amp;author=J.%20Gomez-Galeno&amp;author=D.%20Ryan&amp;author=K.%20Okolotowicz&amp;author=W.L.%20McKeithan&amp;volume=46&amp;publication_year=2021&amp;pages=128162&amp;pmid=34062251&amp;doi=10.1016/j.bmcl.2021.128162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78-biomedicines-11-00334">
<span class="label">78.</span><cite>Wang F., Han Y., Sang W., Wang L., Liang X., Wang L., Xing Q., Guo Y., Zhang J., Zhang L., et al.  In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 &amp; TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells. 2022;11:2495.  doi: 10.3390/cells11162495.</cite> [<a href="https://doi.org/10.3390/cells11162495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9406448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36010573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=In%20Vitro%20Drug%20Screening%20Using%20iPSC-Derived%20Cardiomyocytes%20of%20a%20Long%20QT-Syndrome%20Patient%20Carrying%20KCNQ1%20&amp;%20TRPM4%20Dual%20Mutation:%20An%20Experimental%20Personalized%20Treatment&amp;author=F.%20Wang&amp;author=Y.%20Han&amp;author=W.%20Sang&amp;author=L.%20Wang&amp;author=X.%20Liang&amp;volume=11&amp;publication_year=2022&amp;pages=2495&amp;pmid=36010573&amp;doi=10.3390/cells11162495&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79-biomedicines-11-00334">
<span class="label">79.</span><cite>Duncan G., Firth K., George V., Hoang M.D., Staniforth A., Smith G., Denning C. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells Dev. 2017;26:1695–1705. doi: 10.1089/scd.2017.0172.</cite> [<a href="https://doi.org/10.1089/scd.2017.0172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5706629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28992755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells%20Dev.&amp;title=Drug-Mediated%20Shortening%20of%20Action%20Potentials%20in%20LQTS2%20Human%20Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=G.%20Duncan&amp;author=K.%20Firth&amp;author=V.%20George&amp;author=M.D.%20Hoang&amp;author=A.%20Staniforth&amp;volume=26&amp;publication_year=2017&amp;pages=1695-1705&amp;pmid=28992755&amp;doi=10.1089/scd.2017.0172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80-biomedicines-11-00334">
<span class="label">80.</span><cite>Mehta A., Ramachandra C.J.A., Singh P., Chitre A., Lua C.H., Mura M., Crotti L., Wong P., Schwartz P.J., Gnecchi M., et al.  Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. Eur. Heart J. 2018;39:1446–1455. doi: 10.1093/eurheartj/ehx394.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29020304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Identification%20of%20a%20targeted%20and%20testable%20antiarrhythmic%20therapy%20for%20long-QT%20syndrome%20type%202%20using%20a%20patient-specific%20cellular%20model&amp;author=A.%20Mehta&amp;author=C.J.A.%20Ramachandra&amp;author=P.%20Singh&amp;author=A.%20Chitre&amp;author=C.H.%20Lua&amp;volume=39&amp;publication_year=2018&amp;pages=1446-1455&amp;pmid=29020304&amp;doi=10.1093/eurheartj/ehx394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81-biomedicines-11-00334">
<span class="label">81.</span><cite>O’Hare B.J., Kim C.J., Hamrick S.K., Ye D., Tester D.J., Ackerman M.J. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes. Circ. Genom. Precis. Med. 2020;13:466–475. doi: 10.1161/CIRCGEN.120.002950.</cite> [<a href="https://doi.org/10.1161/CIRCGEN.120.002950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32940533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Genom.%20Precis.%20Med.&amp;title=Promise%20and%20Potential%20Peril%20With%20Lumacaftor%20for%20the%20Trafficking%20Defective%20Type%202%20Long-QT%20Syndrome-Causative%20Variants,%20p.G604S,%20p.N633S,%20and%20p.R685P,%20Using%20Patient-Specific%20Re-Engineered%20Cardiomyocytes&amp;author=B.J.%20O%E2%80%99Hare&amp;author=C.J.%20Kim&amp;author=S.K.%20Hamrick&amp;author=D.%20Ye&amp;author=D.J.%20Tester&amp;volume=13&amp;publication_year=2020&amp;pages=466-475&amp;pmid=32940533&amp;doi=10.1161/CIRCGEN.120.002950&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82-biomedicines-11-00334">
<span class="label">82.</span><cite>Perry M.D., Ng C.A., Mangala M.M., Ng T.Y.M., Hines A.D., Liang W., Xu M.J.O., Hill A.P., Vandenberg J.I. Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization. Cardiovasc. Res. 2019;116:1434–1445. doi: 10.1093/cvr/cvz247.</cite> [<a href="https://doi.org/10.1093/cvr/cvz247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31628797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Pharmacological%20activation%20of%20IKr%20in%20models%20of%20long%20QT%20Type%202%20risks%20overcorrection%20of%20repolarization&amp;author=M.D.%20Perry&amp;author=C.A.%20Ng&amp;author=M.M.%20Mangala&amp;author=T.Y.M.%20Ng&amp;author=A.D.%20Hines&amp;volume=116&amp;publication_year=2019&amp;pages=1434-1445&amp;pmid=31628797&amp;doi=10.1093/cvr/cvz247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83-biomedicines-11-00334">
<span class="label">83.</span><cite>Miller D.C., Harmer S.C., Poliandri A., Nobles M., Edwards E.C., Ware J.S., Sharp T.V., McKay T.R., Dunkel L., Lambiase P.D., et al.  Ajmaline blocks I Na and I Kr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters. Stem Cell Res. 2017;25:233–244. doi: 10.1016/j.scr.2017.11.003.</cite> [<a href="https://doi.org/10.1016/j.scr.2017.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5727153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29172153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Res.&amp;title=Ajmaline%20blocks%20I%20Na%20and%20I%20Kr%20without%20eliciting%20differences%20between%20Brugada%20syndrome%20patient%20and%20control%20human%20pluripotent%20stem%20cell-derived%20cardiac%20clusters&amp;author=D.C.%20Miller&amp;author=S.C.%20Harmer&amp;author=A.%20Poliandri&amp;author=M.%20Nobles&amp;author=E.C.%20Edwards&amp;volume=25&amp;publication_year=2017&amp;pages=233-244&amp;pmid=29172153&amp;doi=10.1016/j.scr.2017.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84-biomedicines-11-00334">
<span class="label">84.</span><cite>El-Battrawy I., Albers S., Cyganek L., Zhao Z., Lan H., Li X., Xu Q., Kleinsorge M., Huang M., Liao Z., et al.  A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes. Europace. 2019;21:1410–1421. doi: 10.1093/europace/euz122.</cite> [<a href="https://doi.org/10.1093/europace/euz122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31106349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=A%20cellular%20model%20of%20Brugada%20syndrome%20with%20SCN10A%20variants%20using%20human-induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes&amp;author=I.%20El-Battrawy&amp;author=S.%20Albers&amp;author=L.%20Cyganek&amp;author=Z.%20Zhao&amp;author=H.%20Lan&amp;volume=21&amp;publication_year=2019&amp;pages=1410-1421&amp;pmid=31106349&amp;doi=10.1093/europace/euz122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85-biomedicines-11-00334">
<span class="label">85.</span><cite>El-Battrawy I., Müller J., Zhao Z., Cyganek L., Zhong R., Zhang F., Kleinsorge M., Lan H., Li X., Xu Q., et al.  Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Front. Cell Dev. Biol. 2019;7:261. doi: 10.3389/fcell.2019.00261.</cite> [<a href="https://doi.org/10.3389/fcell.2019.00261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6839339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31737628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell%20Dev.%20Biol.&amp;title=Studying%20Brugada%20Syndrome%20With%20an%20SCN1B%20Variants%20in%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes&amp;author=I.%20El-Battrawy&amp;author=J.%20M%C3%BCller&amp;author=Z.%20Zhao&amp;author=L.%20Cyganek&amp;author=R.%20Zhong&amp;volume=7&amp;publication_year=2019&amp;pages=261&amp;pmid=31737628&amp;doi=10.3389/fcell.2019.00261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86-biomedicines-11-00334">
<span class="label">86.</span><cite>Zhao Z., Li X., El-Battrawy I., Lan H., Zhong R., Xu Q., Huang M., Liao Z., Lang S., Zimmermann W., et al.  Drug Testing in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. Clin. Pharmacol. Ther. 2019;106:642–651. doi: 10.1002/cpt.1449.</cite> [<a href="https://doi.org/10.1002/cpt.1449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30947366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&amp;title=Drug%20Testing%20in%20Human-Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes%20From%20a%20Patient%20With%20Short%20QT%20Syndrome%20Type%201&amp;author=Z.%20Zhao&amp;author=X.%20Li&amp;author=I.%20El-Battrawy&amp;author=H.%20Lan&amp;author=R.%20Zhong&amp;volume=106&amp;publication_year=2019&amp;pages=642-651&amp;pmid=30947366&amp;doi=10.1002/cpt.1449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87-biomedicines-11-00334">
<span class="label">87.</span><cite>Schweitzer M.K., Wilting F., Sedej S., Dreizehnter L., Dupper N.J., Tian Q., Moretti A., My I., Kwon O., Priori S.G., et al.  Suppression of Arrhythmia by Enhancing Mitochondrial Ca2+ Uptake in Catecholaminergic Ventricular Tachycardia Models. JACC Basic Transl. Sci. 2017;2:737–747. doi: 10.1016/j.jacbts.2017.06.008.</cite> [<a href="https://doi.org/10.1016/j.jacbts.2017.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5774336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29354781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Basic%20Transl.%20Sci.&amp;title=Suppression%20of%20Arrhythmia%20by%20Enhancing%20Mitochondrial%20Ca2+%20Uptake%20in%20Catecholaminergic%20Ventricular%20Tachycardia%20Models&amp;author=M.K.%20Schweitzer&amp;author=F.%20Wilting&amp;author=S.%20Sedej&amp;author=L.%20Dreizehnter&amp;author=N.J.%20Dupper&amp;volume=2&amp;publication_year=2017&amp;pages=737-747&amp;pmid=29354781&amp;doi=10.1016/j.jacbts.2017.06.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B88-biomedicines-11-00334">
<span class="label">88.</span><cite>Sander P., Feng M., Schweitzer M.K., Wilting F., Gutenthaler S.M., Arduino D.M., Fischbach S., Dreizehnter L., Moretti A., Gudermann T., et al.  Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca 2+ uptake and suppress cardiac arrhythmogenesis. Br. J. Pharmacol. 2021;178:4518–4532. doi: 10.1111/bph.15630.</cite> [<a href="https://doi.org/10.1111/bph.15630" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34287836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Approved%20drugs%20ezetimibe%20and%20disulfiram%20enhance%20mitochondrial%20Ca%202+%20uptake%20and%20suppress%20cardiac%20arrhythmogenesis&amp;author=P.%20Sander&amp;author=M.%20Feng&amp;author=M.K.%20Schweitzer&amp;author=F.%20Wilting&amp;author=S.M.%20Gutenthaler&amp;volume=178&amp;publication_year=2021&amp;pages=4518-4532&amp;pmid=34287836&amp;doi=10.1111/bph.15630&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B89-biomedicines-11-00334">
<span class="label">89.</span><cite>Bezzerides V.J., Caballero A., Wang S., Ai Y., Hylind R.J., Lu F., Heims-Waldron D.A., Chambers K.D., Zhang D., Abrams D.J., et al.  Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca 2+ /Calmodulin-Dependent Kinase II. Circulation. 2019;140:405–419. doi: 10.1161/CIRCULATIONAHA.118.038514.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.118.038514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7274838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31155924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Gene%20Therapy%20for%20Catecholaminergic%20Polymorphic%20Ventricular%20Tachycardia%20by%20Inhibition%20of%20Ca%202+%20/Calmodulin-Dependent%20Kinase%20II&amp;author=V.J.%20Bezzerides&amp;author=A.%20Caballero&amp;author=S.%20Wang&amp;author=Y.%20Ai&amp;author=R.J.%20Hylind&amp;volume=140&amp;publication_year=2019&amp;pages=405-419&amp;pmid=31155924&amp;doi=10.1161/CIRCULATIONAHA.118.038514&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B90-biomedicines-11-00334">
<span class="label">90.</span><cite>Schwartz P.J., Gnecchi M., Dagradi F., Castelletti S., Parati G., Spazzolini C., Sala L., Crotti L. From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2. Eur. Heart J. 2019;40:1832–1836. doi: 10.1093/eurheartj/ehz023.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30753398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=From%20patient-specific%20induced%20pluripotent%20stem%20cells%20to%20clinical%20translation%20in%20long%20QT%20syndrome%20Type%202&amp;author=P.J.%20Schwartz&amp;author=M.%20Gnecchi&amp;author=F.%20Dagradi&amp;author=S.%20Castelletti&amp;author=G.%20Parati&amp;volume=40&amp;publication_year=2019&amp;pages=1832-1836&amp;pmid=30753398&amp;doi=10.1093/eurheartj/ehz023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B91-biomedicines-11-00334">
<span class="label">91.</span><cite>Li Y., Lang S., Akin I., Zhou X., El-Battrawy I. Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells. J. Am. Heart Assoc. 2022;11:e024410. doi: 10.1161/JAHA.121.024410.</cite> [<a href="https://doi.org/10.1161/JAHA.121.024410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9075459/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35322667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=Brugada%20Syndrome:%20Different%20Experimental%20Models%20and%20the%20Role%20of%20Human%20Cardiomyocytes%20From%20Induced%20Pluripotent%20Stem%20Cells&amp;author=Y.%20Li&amp;author=S.%20Lang&amp;author=I.%20Akin&amp;author=X.%20Zhou&amp;author=I.%20El-Battrawy&amp;volume=11&amp;publication_year=2022&amp;pages=e024410&amp;pmid=35322667&amp;doi=10.1161/JAHA.121.024410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B92-biomedicines-11-00334">
<span class="label">92.</span><cite>Matsa E., Dixon J.E., Medway C., Georgiou O., Patel M.J., Morgan K., Kemp P.J., Staniforth A., Mellor I., Denning C. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes. Eur. Heart J. 2014;35:1078–1087. doi: 10.1093/eurheartj/eht067.</cite> [<a href="https://doi.org/10.1093/eurheartj/eht067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3992427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23470493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Allele-specific%20RNA%20interference%20rescues%20the%20long-QT%20syndrome%20phenotype%20in%20human-induced%20pluripotency%20stem%20cell%20cardiomyocytes&amp;author=E.%20Matsa&amp;author=J.E.%20Dixon&amp;author=C.%20Medway&amp;author=O.%20Georgiou&amp;author=M.J.%20Patel&amp;volume=35&amp;publication_year=2014&amp;pages=1078-1087&amp;pmid=23470493&amp;doi=10.1093/eurheartj/eht067&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B93-biomedicines-11-00334">
<span class="label">93.</span><cite>Dotzler S.M., Kim C.J., Gendron W.A., Zhou W., Ye D., Bos J.M., Tester D.J., Barry M.A., Ackerman M.J. Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome. Circulation. 2021;143:1411–1425. doi: 10.1161/CIRCULATIONAHA.120.051836.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.120.051836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33504163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Suppression-Replacement%20KCNQ1%20Gene%20Therapy%20for%20Type%201%20Long%20QT%20Syndrome&amp;author=S.M.%20Dotzler&amp;author=C.J.%20Kim&amp;author=W.A.%20Gendron&amp;author=W.%20Zhou&amp;author=D.%20Ye&amp;volume=143&amp;publication_year=2021&amp;pages=1411-1425&amp;pmid=33504163&amp;doi=10.1161/CIRCULATIONAHA.120.051836&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B94-biomedicines-11-00334">
<span class="label">94.</span><cite>Bains S., Zhou W., Dotzler S.M., Martinez K., Kim C.J., Tester D.J., Ye D., Ackerman M.J. Suppression and Replacement Gene Therapy for KCNH2 -Mediated Arrhythmias. Circ. Genom. Precis. Med. 2022;15:e003719. doi: 10.1161/CIRCGEN.122.003719.</cite> [<a href="https://doi.org/10.1161/CIRCGEN.122.003719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36252106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Genom.%20Precis.%20Med.&amp;title=Suppression%20and%20Replacement%20Gene%20Therapy%20for%20KCNH2%20-Mediated%20Arrhythmias&amp;author=S.%20Bains&amp;author=W.%20Zhou&amp;author=S.M.%20Dotzler&amp;author=K.%20Martinez&amp;author=C.J.%20Kim&amp;volume=15&amp;publication_year=2022&amp;pages=e003719&amp;pmid=36252106&amp;doi=10.1161/CIRCGEN.122.003719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B95-biomedicines-11-00334">
<span class="label">95.</span><cite>Stillitano F., Hansen J., Kong C.-W., Karakikes I., Funck-Brentano C., Geng L., Scott S., Reynier S., Wu M., Valogne Y., et al.  Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells. eLife. 2017;6:e19406. doi: 10.7554/eLife.19406.</cite> [<a href="https://doi.org/10.7554/eLife.19406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5279943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28134617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eLife&amp;title=Modeling%20susceptibility%20to%20drug-induced%20long%20QT%20with%20a%20panel%20of%20subject-specific%20induced%20pluripotent%20stem%20cells&amp;author=F.%20Stillitano&amp;author=J.%20Hansen&amp;author=C.-W.%20Kong&amp;author=I.%20Karakikes&amp;author=C.%20Funck-Brentano&amp;volume=6&amp;publication_year=2017&amp;pages=e19406&amp;pmid=28134617&amp;doi=10.7554/eLife.19406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B96-biomedicines-11-00334">
<span class="label">96.</span><cite>Shinozawa T., Nakamura K., Shoji M., Morita M., Kimura M., Furukawa H., Ueda H., Shiramoto M., Matsuguma K., Kaji Y., et al.  Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. Stem Cell Rep. 2017;8:226–234. doi: 10.1016/j.stemcr.2016.12.014.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2016.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5312248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28111276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Rep.&amp;title=Recapitulation%20of%20Clinical%20Individual%20Susceptibility%20to%20Drug-Induced%20QT%20Prolongation%20in%20Healthy%20Subjects%20Using%20iPSC-Derived%20Cardiomyocytes&amp;author=T.%20Shinozawa&amp;author=K.%20Nakamura&amp;author=M.%20Shoji&amp;author=M.%20Morita&amp;author=M.%20Kimura&amp;volume=8&amp;publication_year=2017&amp;pages=226-234&amp;pmid=28111276&amp;doi=10.1016/j.stemcr.2016.12.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B97-biomedicines-11-00334">
<span class="label">97.</span><cite>Blinova K., Schocken D., Patel D., Daluwatte C., Vicente J., Wu J.C., Strauss D.G. Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT -Prolonging Drugs. Clin. Transl. Sci. 2019;12:687–697. doi: 10.1111/cts.12674.</cite> [<a href="https://doi.org/10.1111/cts.12674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6853144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31328865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Transl.%20Sci.&amp;title=Clinical%20Trial%20in%20a%20Dish:%20Personalized%20Stem%20Cell%E2%80%93Derived%20Cardiomyocyte%20Assay%20Compared%20With%20Clinical%20Trial%20Results%20for%20Two%20QT%20-Prolonging%20Drugs&amp;author=K.%20Blinova&amp;author=D.%20Schocken&amp;author=D.%20Patel&amp;author=C.%20Daluwatte&amp;author=J.%20Vicente&amp;volume=12&amp;publication_year=2019&amp;pages=687-697&amp;pmid=31328865&amp;doi=10.1111/cts.12674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B98-biomedicines-11-00334">
<span class="label">98.</span><cite>Volpato V., Webber C. Addressing variability in iPSC-derived models of human disease: Guidelines to promote reproducibility. Dis. Model. Mech. 2020;13:dmm042317. doi: 10.1242/dmm.042317.</cite> [<a href="https://doi.org/10.1242/dmm.042317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6994963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31953356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis.%20Model.%20Mech.&amp;title=Addressing%20variability%20in%20iPSC-derived%20models%20of%20human%20disease:%20Guidelines%20to%20promote%20reproducibility&amp;author=V.%20Volpato&amp;author=C.%20Webber&amp;volume=13&amp;publication_year=2020&amp;pages=dmm042317&amp;pmid=31953356&amp;doi=10.1242/dmm.042317&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B99-biomedicines-11-00334">
<span class="label">99.</span><cite>Veerman C.C., Mengarelli I., Guan K., Stauske M., Barc J., Tan H.L., Wilde A.A.M., Verkerk A.O., Bezzina C.R. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities. Sci. Rep. 2016;6:30967. doi: 10.1038/srep30967.</cite> [<a href="https://doi.org/10.1038/srep30967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4971529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27485484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=hiPSC-derived%20cardiomyocytes%20from%20Brugada%20Syndrome%20patients%20without%20identified%20mutations%20do%20not%20exhibit%20clear%20cellular%20electrophysiological%20abnormalities&amp;author=C.C.%20Veerman&amp;author=I.%20Mengarelli&amp;author=K.%20Guan&amp;author=M.%20Stauske&amp;author=J.%20Barc&amp;volume=6&amp;publication_year=2016&amp;pages=30967&amp;pmid=27485484&amp;doi=10.1038/srep30967&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B100-biomedicines-11-00334">
<span class="label">100.</span><cite>Kerr C., Richards D., Menick D., Deleon-Pennell K., Mei Y. Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult Myocardium. Int. J. Mol. Sci. 2021;22:8482.  doi: 10.3390/ijms22168482.</cite> [<a href="https://doi.org/10.3390/ijms22168482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8395156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34445185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Multicellular%20Human%20Cardiac%20Organoids%20Transcriptomically%20Model%20Distinct%20Tissue-Level%20Features%20of%20Adult%20Myocardium&amp;author=C.%20Kerr&amp;author=D.%20Richards&amp;author=D.%20Menick&amp;author=K.%20Deleon-Pennell&amp;author=Y.%20Mei&amp;volume=22&amp;publication_year=2021&amp;pages=8482&amp;pmid=34445185&amp;doi=10.3390/ijms22168482&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B101-biomedicines-11-00334">
<span class="label">101.</span><cite>Feng W., Schriever H., Jiang S., Bais A., Wu H., Kostka D., Li G. Computational profiling of hiPSC-derived heart organoids reveals chamber defects associated with NKX2-5 deficiency. Commun. Biol. 2022;5:399. doi: 10.1038/s42003-022-03346-4.</cite> [<a href="https://doi.org/10.1038/s42003-022-03346-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9054831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35488063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun.%20Biol.&amp;title=Computational%20profiling%20of%20hiPSC-derived%20heart%20organoids%20reveals%20chamber%20defects%20associated%20with%20NKX2-5%20deficiency&amp;author=W.%20Feng&amp;author=H.%20Schriever&amp;author=S.%20Jiang&amp;author=A.%20Bais&amp;author=H.%20Wu&amp;volume=5&amp;publication_year=2022&amp;pages=399&amp;pmid=35488063&amp;doi=10.1038/s42003-022-03346-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B102-biomedicines-11-00334">
<span class="label">102.</span><cite>Egashira T., Yuasa S., Suzuki T., Aizawa Y., Yamakawa H., Matsuhashi T., Ohno Y., Tohyama S., Okata S., Seki T., et al.  Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc. Res. 2012;95:419–429. doi: 10.1093/cvr/cvs206.</cite> [<a href="https://doi.org/10.1093/cvr/cvs206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22739119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Disease%20characterization%20using%20LQTS-specific%20induced%20pluripotent%20stem%20cells&amp;author=T.%20Egashira&amp;author=S.%20Yuasa&amp;author=T.%20Suzuki&amp;author=Y.%20Aizawa&amp;author=H.%20Yamakawa&amp;volume=95&amp;publication_year=2012&amp;pages=419-429&amp;pmid=22739119&amp;doi=10.1093/cvr/cvs206&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B103-biomedicines-11-00334">
<span class="label">103.</span><cite>Ma D., Wei H., Lu J., Huang D., Liu Z., Loh L.J., Islam O., Liew R., Shim W., Cook S.A. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes. Stem. Cell Res. Ther. 2015;6:39. doi: 10.1186/s13287-015-0027-z.</cite> [<a href="https://doi.org/10.1186/s13287-015-0027-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4396080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25889101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem.%20Cell%20Res.%20Ther.&amp;title=Characterization%20of%20a%20novel%20KCNQ1%20mutation%20for%20type%201%20long%20QT%20syndrome%20and%20assessment%20of%20the%20therapeutic%20potential%20of%20a%20novel%20IKs%20activator%20using%20patient-specific%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes&amp;author=D.%20Ma&amp;author=H.%20Wei&amp;author=J.%20Lu&amp;author=D.%20Huang&amp;author=Z.%20Liu&amp;volume=6&amp;publication_year=2015&amp;pages=39&amp;pmid=25889101&amp;doi=10.1186/s13287-015-0027-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B104-biomedicines-11-00334">
<span class="label">104.</span><cite>Sala L., Yu Z., Ward-van Oostwaard D., van Veldhoven J.P., Moretti A., Laugwitz K.L., Mummery C.L., AP I.J., Bellin M. A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol. Med. 2016;8:1065–1081. doi: 10.15252/emmm.201606260.</cite> [<a href="https://doi.org/10.15252/emmm.201606260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5009811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27470144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Mol.%20Med.&amp;title=A%20new%20hERG%20allosteric%20modulator%20rescues%20genetic%20and%20drug-induced%20long-QT%20syndrome%20phenotypes%20in%20cardiomyocytes%20from%20isogenic%20pairs%20of%20patient%20induced%20pluripotent%20stem%20cells&amp;author=L.%20Sala&amp;author=Z.%20Yu&amp;author=D.%20Ward-van%20Oostwaard&amp;author=J.P.%20van%20Veldhoven&amp;author=A.%20Moretti&amp;volume=8&amp;publication_year=2016&amp;pages=1065-1081&amp;pmid=27470144&amp;doi=10.15252/emmm.201606260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B105-biomedicines-11-00334">
<span class="label">105.</span><cite>Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., Feldman O., Gepstein A., Arbel G., Hammerman H., et al.  Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471:225–229. doi: 10.1038/nature09747.</cite> [<a href="https://doi.org/10.1038/nature09747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21240260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Modelling%20the%20long%20QT%20syndrome%20with%20induced%20pluripotent%20stem%20cells&amp;author=I.%20Itzhaki&amp;author=L.%20Maizels&amp;author=I.%20Huber&amp;author=L.%20Zwi-Dantsis&amp;author=O.%20Caspi&amp;volume=471&amp;publication_year=2011&amp;pages=225-229&amp;pmid=21240260&amp;doi=10.1038/nature09747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B106-biomedicines-11-00334">
<span class="label">106.</span><cite>Lahti A.L., Kujala V.J., Chapman H., Koivisto A.P., Pekkanen-Mattila M., Kerkela E., Hyttinen J., Kontula K., Swan H., Conklin B.R., et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis. Model. Mech. 2012;5:220–230. doi: 10.1242/dmm.008409.</cite> [<a href="https://doi.org/10.1242/dmm.008409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3291643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22052944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis.%20Model.%20Mech.&amp;title=Model%20for%20long%20QT%20syndrome%20type%202%20using%20human%20iPS%20cells%20demonstrates%20arrhythmogenic%20characteristics%20in%20cell%20culture&amp;author=A.L.%20Lahti&amp;author=V.J.%20Kujala&amp;author=H.%20Chapman&amp;author=A.P.%20Koivisto&amp;author=M.%20Pekkanen-Mattila&amp;volume=5&amp;publication_year=2012&amp;pages=220-230&amp;pmid=22052944&amp;doi=10.1242/dmm.008409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B107-biomedicines-11-00334">
<span class="label">107.</span><cite>Terrenoire C., Wang K., Tung K.W., Chung W.K., Pass R.H., Lu J.T., Jean J.C., Omari A., Sampson K.J., Kotton D.N., et al.  Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J. Gen. Physiol. 2013;141:61–72. doi: 10.1085/jgp.201210899.</cite> [<a href="https://doi.org/10.1085/jgp.201210899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3536519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23277474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Gen.%20Physiol.&amp;title=Induced%20pluripotent%20stem%20cells%20used%20to%20reveal%20drug%20actions%20in%20a%20long%20QT%20syndrome%20family%20with%20complex%20genetics&amp;author=C.%20Terrenoire&amp;author=K.%20Wang&amp;author=K.W.%20Tung&amp;author=W.K.%20Chung&amp;author=R.H.%20Pass&amp;volume=141&amp;publication_year=2013&amp;pages=61-72&amp;pmid=23277474&amp;doi=10.1085/jgp.201210899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B108-biomedicines-11-00334">
<span class="label">108.</span><cite>Ma D., Wei H., Zhao Y., Lu J., Li G., Sahib N.B., Tan T.H., Wong K.Y., Shim W., Wong P., et al.  Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int. J. Cardiol. 2013;168:5277–5286. doi: 10.1016/j.ijcard.2013.08.015.</cite> [<a href="https://doi.org/10.1016/j.ijcard.2013.08.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23998552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cardiol.&amp;title=Modeling%20type%203%20long%20QT%20syndrome%20with%20cardiomyocytes%20derived%20from%20patient-specific%20induced%20pluripotent%20stem%20cells&amp;author=D.%20Ma&amp;author=H.%20Wei&amp;author=Y.%20Zhao&amp;author=J.%20Lu&amp;author=G.%20Li&amp;volume=168&amp;publication_year=2013&amp;pages=5277-5286&amp;pmid=23998552&amp;doi=10.1016/j.ijcard.2013.08.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B109-biomedicines-11-00334">
<span class="label">109.</span><cite>Fatima A., Kaifeng S., Dittmann S., Xu G., Gupta M.K., Linke M., Zechner U., Nguemo F., Milting H., Farr M., et al.  The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS ONE. 2013;8:e83005.  doi: 10.1371/journal.pone.0083005.</cite> [<a href="https://doi.org/10.1371/journal.pone.0083005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3859612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24349418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=The%20disease-specific%20phenotype%20in%20cardiomyocytes%20derived%20from%20induced%20pluripotent%20stem%20cells%20of%20two%20long%20QT%20syndrome%20type%203%20patients&amp;author=A.%20Fatima&amp;author=S.%20Kaifeng&amp;author=S.%20Dittmann&amp;author=G.%20Xu&amp;author=M.K.%20Gupta&amp;volume=8&amp;publication_year=2013&amp;pages=e83005&amp;pmid=24349418&amp;doi=10.1371/journal.pone.0083005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B110-biomedicines-11-00334">
<span class="label">110.</span><cite>Malan D., Zhang M., Stallmeyer B., Muller J., Fleischmann B.K., Schulze-Bahr E., Sasse P., Greber B. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Res. Cardiol. 2016;111:14. doi: 10.1007/s00395-016-0530-0.</cite> [<a href="https://doi.org/10.1007/s00395-016-0530-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4724360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26803770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20Res.%20Cardiol.&amp;title=Human%20iPS%20cell%20model%20of%20type%203%20long%20QT%20syndrome%20recapitulates%20drug-based%20phenotype%20correction&amp;author=D.%20Malan&amp;author=M.%20Zhang&amp;author=B.%20Stallmeyer&amp;author=J.%20Muller&amp;author=B.K.%20Fleischmann&amp;volume=111&amp;publication_year=2016&amp;pages=14&amp;pmid=26803770&amp;doi=10.1007/s00395-016-0530-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B111-biomedicines-11-00334">
<span class="label">111.</span><cite>Kuroda Y., Yuasa S., Watanabe Y., Ito S., Egashira T., Seki T., Hattori T., Ohno S., Kodaira M., Suzuki T., et al.  Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes. Biochem. Biophys. Rep. 2017;9:245–256. doi: 10.1016/j.bbrep.2017.01.002.</cite> [<a href="https://doi.org/10.1016/j.bbrep.2017.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5614591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28956012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Rep.&amp;title=Flecainide%20ameliorates%20arrhythmogenicity%20through%20NCX%20flux%20in%20Andersen-Tawil%20syndrome-iPS%20cell-derived%20cardiomyocytes&amp;author=Y.%20Kuroda&amp;author=S.%20Yuasa&amp;author=Y.%20Watanabe&amp;author=S.%20Ito&amp;author=T.%20Egashira&amp;volume=9&amp;publication_year=2017&amp;pages=245-256&amp;pmid=28956012&amp;doi=10.1016/j.bbrep.2017.01.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B112-biomedicines-11-00334">
<span class="label">112.</span><cite>Yazawa M., Dolmetsch R.E. Modeling Timothy syndrome with iPS cells. J. Cardiovasc. Transl. Res. 2013;6:1–9. doi: 10.1007/s12265-012-9444-x.</cite> [<a href="https://doi.org/10.1007/s12265-012-9444-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3637984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23299782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cardiovasc.%20Transl.%20Res.&amp;title=Modeling%20Timothy%20syndrome%20with%20iPS%20cells&amp;author=M.%20Yazawa&amp;author=R.E.%20Dolmetsch&amp;volume=6&amp;publication_year=2013&amp;pages=1-9&amp;pmid=23299782&amp;doi=10.1007/s12265-012-9444-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B113-biomedicines-11-00334">
<span class="label">113.</span><cite>Rocchetti M., Sala L., Dreizehnter L., Crotti L., Sinnecker D., Mura M., Pane L.S., Altomare C., Torre E., Mostacciuolo G., et al.  Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes. Cardiovasc. Res. 2017;113:531–541. doi: 10.1093/cvr/cvx006.</cite> [<a href="https://doi.org/10.1093/cvr/cvx006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28158429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc.%20Res.&amp;title=Elucidating%20arrhythmogenic%20mechanisms%20of%20long-QT%20syndrome%20CALM1-F142L%20mutation%20in%20patient-specific%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes&amp;author=M.%20Rocchetti&amp;author=L.%20Sala&amp;author=L.%20Dreizehnter&amp;author=L.%20Crotti&amp;author=D.%20Sinnecker&amp;volume=113&amp;publication_year=2017&amp;pages=531-541&amp;pmid=28158429&amp;doi=10.1093/cvr/cvx006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B114-biomedicines-11-00334">
<span class="label">114.</span><cite>Yamamoto Y., Makiyama T., Harita T., Sasaki K., Wuriyanghai Y., Hayano M., Nishiuchi S., Kohjitani H., Hirose S., Chen J., et al.  Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation. Hum. Mol. Genet. 2017;26:1670–1677. doi: 10.1093/hmg/ddx073.</cite> [<a href="https://doi.org/10.1093/hmg/ddx073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28335032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Allele-specific%20ablation%20rescues%20electrophysiological%20abnormalities%20in%20a%20human%20iPS%20cell%20model%20of%20long-QT%20syndrome%20with%20a%20CALM2%20mutation&amp;author=Y.%20Yamamoto&amp;author=T.%20Makiyama&amp;author=T.%20Harita&amp;author=K.%20Sasaki&amp;author=Y.%20Wuriyanghai&amp;volume=26&amp;publication_year=2017&amp;pages=1670-1677&amp;pmid=28335032&amp;doi=10.1093/hmg/ddx073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B115-biomedicines-11-00334">
<span class="label">115.</span><cite>Limpitikul W.B., Dick I.E., Tester D.J., Boczek N.J., Limphong P., Yang W., Choi M.H., Babich J., DiSilvestre D., Kanter R.J., et al.  A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome. Circ. Res. 2017;120:39–48. doi: 10.1161/CIRCRESAHA.116.309283.</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.309283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5516949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27765793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=A%20Precision%20Medicine%20Approach%20to%20the%20Rescue%20of%20Function%20on%20Malignant%20Calmodulinopathic%20Long-QT%20Syndrome&amp;author=W.B.%20Limpitikul&amp;author=I.E.%20Dick&amp;author=D.J.%20Tester&amp;author=N.J.%20Boczek&amp;author=P.%20Limphong&amp;volume=120&amp;publication_year=2017&amp;pages=39-48&amp;pmid=27765793&amp;doi=10.1161/CIRCRESAHA.116.309283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B116-biomedicines-11-00334">
<span class="label">116.</span><cite>Cerrone M., Lin X., Zhang M., Agullo-Pascual E., Pfenniger A., Chkourko Gusky H., Novelli V., Kim C., Tirasawadichai T., Judge D.P., et al.  Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation. 2014;129:1092–1103. doi: 10.1161/CIRCULATIONAHA.113.003077.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.113.003077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3954430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24352520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Missense%20mutations%20in%20plakophilin-2%20cause%20sodium%20current%20deficit%20and%20associate%20with%20a%20Brugada%20syndrome%20phenotype&amp;author=M.%20Cerrone&amp;author=X.%20Lin&amp;author=M.%20Zhang&amp;author=E.%20Agullo-Pascual&amp;author=A.%20Pfenniger&amp;volume=129&amp;publication_year=2014&amp;pages=1092-1103&amp;pmid=24352520&amp;doi=10.1161/CIRCULATIONAHA.113.003077&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B117-biomedicines-11-00334">
<span class="label">117.</span><cite>Belbachir N., Portero V., Al Sayed Z.R., Gourraud J.B., Dilasser F., Jesel L., Guo H., Wu H., Gaborit N., Guilluy C., et al.  RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome. Eur Heart J. 2019;40:3081–3094. doi: 10.1093/eurheartj/ehz308.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6769825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31114854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J.&amp;title=RRAD%20mutation%20causes%20electrical%20and%20cytoskeletal%20defects%20in%20cardiomyocytes%20derived%20from%20a%20familial%20case%20of%20Brugada%20syndrome&amp;author=N.%20Belbachir&amp;author=V.%20Portero&amp;author=Z.R.%20Al%20Sayed&amp;author=J.B.%20Gourraud&amp;author=F.%20Dilasser&amp;volume=40&amp;publication_year=2019&amp;pages=3081-3094&amp;pmid=31114854&amp;doi=10.1093/eurheartj/ehz308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B118-biomedicines-11-00334">
<span class="label">118.</span><cite>Kosmidis G., Veerman C.C., Casini S., Verkerk A.O., van de Pas S., Bellin M., Wilde A.A., Mummery C.L., Bezzina C.R. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A. Circ. Arrhythm Electrophysiol. 2016;9:e004227. doi: 10.1161/CIRCEP.116.004227.</cite> [<a href="https://doi.org/10.1161/CIRCEP.116.004227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27784737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Arrhythm%20Electrophysiol.&amp;title=Readthrough-Promoting%20Drugs%20Gentamicin%20and%20PTC124%20Fail%20to%20Rescue%20Nav1.5%20Function%20of%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Cardiomyocytes%20Carrying%20Nonsense%20Mutations%20in%20the%20Sodium%20Channel%20Gene%20SCN5A&amp;author=G.%20Kosmidis&amp;author=C.C.%20Veerman&amp;author=S.%20Casini&amp;author=A.O.%20Verkerk&amp;author=S.%20van%20de%20Pas&amp;volume=9&amp;publication_year=2016&amp;pages=e004227&amp;pmid=27784737&amp;doi=10.1161/CIRCEP.116.004227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B119-biomedicines-11-00334">
<span class="label">119.</span><cite>Ma D., Liu Z., Loh L.J., Zhao Y., Li G., Liew R., Islam O., Wu J., Chung Y.Y., Teo W.S., et al.  Identification of an I(Na)-dependent and I(to)-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patient. Sci. Rep. 2018;8:11246. doi: 10.1038/s41598-018-29574-5.</cite> [<a href="https://doi.org/10.1038/s41598-018-29574-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6062539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30050137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Identification%20of%20an%20I(Na)-dependent%20and%20I(to)-mediated%20proarrhythmic%20mechanism%20in%20cardiomyocytes%20derived%20from%20pluripotent%20stem%20cells%20of%20a%20Brugada%20syndrome%20patient&amp;author=D.%20Ma&amp;author=Z.%20Liu&amp;author=L.J.%20Loh&amp;author=Y.%20Zhao&amp;author=G.%20Li&amp;volume=8&amp;publication_year=2018&amp;pages=11246&amp;pmid=30050137&amp;doi=10.1038/s41598-018-29574-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B120-biomedicines-11-00334">
<span class="label">120.</span><cite>Selga E., Sendfeld F., Martinez-Moreno R., Medine C.N., Tura-Ceide O., Wilmut S.I., Perez G.J., Scornik F.S., Brugada R., Mills N.L. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. J. Mol. Cell Cardiol. 2018;114:10–19. doi: 10.1016/j.yjmcc.2017.10.002.</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2017.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5807028/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29024690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Cell%20Cardiol.&amp;title=Sodium%20channel%20current%20loss%20of%20function%20in%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20from%20a%20Brugada%20syndrome%20patient&amp;author=E.%20Selga&amp;author=F.%20Sendfeld&amp;author=R.%20Martinez-Moreno&amp;author=C.N.%20Medine&amp;author=O.%20Tura-Ceide&amp;volume=114&amp;publication_year=2018&amp;pages=10-19&amp;pmid=29024690&amp;doi=10.1016/j.yjmcc.2017.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B121-biomedicines-11-00334">
<span class="label">121.</span><cite>de la Roche J., Angsutararux P., Kempf H., Janan M., Bolesani E., Thiemann S., Wojciechowski D., Coffee M., Franke A., Schwanke K., et al.  Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na(V)1.5 sodium channels. Sci Rep. 2019;9:11173. doi: 10.1038/s41598-019-47632-4.</cite> [<a href="https://doi.org/10.1038/s41598-019-47632-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6673693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31371804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep.&amp;title=Comparing%20human%20iPSC-cardiomyocytes%20versus%20HEK293T%20cells%20unveils%20disease-causing%20effects%20of%20Brugada%20mutation%20A735V%20of%20Na(V)1.5%20sodium%20channels&amp;author=J.%20de%20la%20Roche&amp;author=P.%20Angsutararux&amp;author=H.%20Kempf&amp;author=M.%20Janan&amp;author=E.%20Bolesani&amp;volume=9&amp;publication_year=2019&amp;pages=11173&amp;pmid=31371804&amp;doi=10.1038/s41598-019-47632-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B122-biomedicines-11-00334">
<span class="label">122.</span><cite>Jung C.B., Moretti A., Mederos y Schnitzler M., Iop L., Storch U., Bellin M., Dorn T., Ruppenthal S., Pfeiffer S., Goedel A., et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Med. 2012;4:180–191. doi: 10.1002/emmm.201100194.</cite> [<a href="https://doi.org/10.1002/emmm.201100194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3376852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22174035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Med.&amp;title=Dantrolene%20rescues%20arrhythmogenic%20RYR2%20defect%20in%20a%20patient-specific%20stem%20cell%20model%20of%20catecholaminergic%20polymorphic%20ventricular%20tachycardia&amp;author=C.B.%20Jung&amp;author=A.%20Moretti&amp;author=M.%20Mederos%20y%20Schnitzler&amp;author=L.%20Iop&amp;author=U.%20Storch&amp;volume=4&amp;publication_year=2012&amp;pages=180-191&amp;pmid=22174035&amp;doi=10.1002/emmm.201100194&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B123-biomedicines-11-00334">
<span class="label">123.</span><cite>Itzhaki I., Maizels L., Huber I., Gepstein A., Arbel G., Caspi O., Miller L., Belhassen B., Nof E., Glikson M., et al.  Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J. Am. Coll Cardiol. 2012;60:990–1000. doi: 10.1016/j.jacc.2012.02.066.</cite> [<a href="https://doi.org/10.1016/j.jacc.2012.02.066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22749309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll%20Cardiol.&amp;title=Modeling%20of%20catecholaminergic%20polymorphic%20ventricular%20tachycardia%20with%20patient-specific%20human-induced%20pluripotent%20stem%20cells&amp;author=I.%20Itzhaki&amp;author=L.%20Maizels&amp;author=I.%20Huber&amp;author=A.%20Gepstein&amp;author=G.%20Arbel&amp;volume=60&amp;publication_year=2012&amp;pages=990-1000&amp;pmid=22749309&amp;doi=10.1016/j.jacc.2012.02.066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B124-biomedicines-11-00334">
<span class="label">124.</span><cite>Preininger M.K., Jha R., Maxwell J.T., Wu Q., Singh M., Wang B., Dalal A., McEachin Z.T., Rossoll W., Hales C.M., et al.  A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses. Dis Model. Mech. 2016;9:927–939. doi: 10.1242/dmm.026823.</cite> [<a href="https://doi.org/10.1242/dmm.026823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5047684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27491078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis%20Model.%20Mech&amp;title=A%20human%20pluripotent%20stem%20cell%20model%20of%20catecholaminergic%20polymorphic%20ventricular%20tachycardia%20recapitulates%20patient-specific%20drug%20responses&amp;author=M.K.%20Preininger&amp;author=R.%20Jha&amp;author=J.T.%20Maxwell&amp;author=Q.%20Wu&amp;author=M.%20Singh&amp;volume=9&amp;publication_year=2016&amp;pages=927-939&amp;pmid=27491078&amp;doi=10.1242/dmm.026823&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B125-biomedicines-11-00334">
<span class="label">125.</span><cite>Sasaki K., Makiyama T., Yoshida Y., Wuriyanghai Y., Kamakura T., Nishiuchi S., Hayano M., Harita T., Yamamoto Y., Kohjitani H., et al.  Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PLoS ONE. 2016;11:e0164795.  doi: 10.1371/journal.pone.0164795.</cite> [<a href="https://doi.org/10.1371/journal.pone.0164795" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5072719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27764147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Patient-Specific%20Human%20Induced%20Pluripotent%20Stem%20Cell%20Model%20Assessed%20with%20Electrical%20Pacing%20Validates%20S107%20as%20a%20Potential%20Therapeutic%20Agent%20for%20Catecholaminergic%20Polymorphic%20Ventricular%20Tachycardia&amp;author=K.%20Sasaki&amp;author=T.%20Makiyama&amp;author=Y.%20Yoshida&amp;author=Y.%20Wuriyanghai&amp;author=T.%20Kamakura&amp;volume=11&amp;publication_year=2016&amp;pages=e0164795&amp;pmid=27764147&amp;doi=10.1371/journal.pone.0164795&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B126-biomedicines-11-00334">
<span class="label">126.</span><cite>Novak A., Barad L., Lorber A., Gherghiceanu M., Reiter I., Eisen B., Eldor L., Itskovitz-Eldor J., Eldar M., Arad M., et al.  Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. J. Cell Mol. Med. 2015;19:2006–2018. doi: 10.1111/jcmm.12581.</cite> [<a href="https://doi.org/10.1111/jcmm.12581" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4549051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26153920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell%20Mol.%20Med.&amp;title=Functional%20abnormalities%20in%20iPSC-derived%20cardiomyocytes%20generated%20from%20CPVT1%20and%20CPVT2%20patients%20carrying%20ryanodine%20or%20calsequestrin%20mutations&amp;author=A.%20Novak&amp;author=L.%20Barad&amp;author=A.%20Lorber&amp;author=M.%20Gherghiceanu&amp;author=I.%20Reiter&amp;volume=19&amp;publication_year=2015&amp;pages=2006-2018&amp;pmid=26153920&amp;doi=10.1111/jcmm.12581&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B127-biomedicines-11-00334">
<span class="label">127.</span><cite>Maizels L., Huber I., Arbel G., Tijsen A.J., Gepstein A., Khoury A., Gepstein L. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2. Circ. Arrhythm Electrophysiol. 2017;10:e004725. doi: 10.1161/CIRCEP.116.004725.</cite> [<a href="https://doi.org/10.1161/CIRCEP.116.004725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28630169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Arrhythm%20Electrophysiol.&amp;title=Patient-Specific%20Drug%20Screening%20Using%20a%20Human%20Induced%20Pluripotent%20Stem%20Cell%20Model%20of%20Catecholaminergic%20Polymorphic%20Ventricular%20Tachycardia%20Type%202&amp;author=L.%20Maizels&amp;author=I.%20Huber&amp;author=G.%20Arbel&amp;author=A.J.%20Tijsen&amp;author=A.%20Gepstein&amp;volume=10&amp;publication_year=2017&amp;pages=e004725&amp;pmid=28630169&amp;doi=10.1161/CIRCEP.116.004725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B128-biomedicines-11-00334">
<span class="label">128.</span><cite>Kim C., Wong J., Wen J., Wang S., Wang C., Spiering S., Kan N.G., Forcales S., Puri P.L., Leone T.C., et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 2013;494:105–110. doi: 10.1038/nature11799.</cite> [<a href="https://doi.org/10.1038/nature11799" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3753229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23354045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Studying%20arrhythmogenic%20right%20ventricular%20dysplasia%20with%20patient-specific%20iPSCs&amp;author=C.%20Kim&amp;author=J.%20Wong&amp;author=J.%20Wen&amp;author=S.%20Wang&amp;author=C.%20Wang&amp;volume=494&amp;publication_year=2013&amp;pages=105-110&amp;pmid=23354045&amp;doi=10.1038/nature11799&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9953535/bin/biomedicines-11-00334-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (142.7KB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Biomedicines are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/biomedicines11020334"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/biomedicines-11-00334.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (656.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9953535/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9953535/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9953535%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9953535/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9953535/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9953535/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36830871/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9953535/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36830871/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9953535/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9953535/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="30NW0VXCexRlJjccSU8jbc1jB8WKHimdYblLeb6ejUN9a8v7HZjE5UkMbE1bgrZP">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
